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ABSTRACT 
The aim of this descriptive study was to assess, using Cohen's Kappa statistic, the agreement between 
hospitalized patients with cancer and their closest family member, and between these patients and 
the nurse providing the bedside care, on the perceptions of cancer-related symptoms. 
One hundred patients, hospitalized because of a malignancy, rated nine cancer-related symptoms 
using the Edmonton Symptom Assessment System, a colledion of nine Visual Analogue Scates. 
Simultaneously, the closest family member and the nurse providing the bedside care rated the 
patients' symptoms using the same method. The aim of the study was to assess agreement, on these 
nine symptoms, between the patients and the family members. and between the patients and their 
nurses. 
Family members demonstrated significant agreement (Cohen's Kappa > 0.35) with the patient in 
assessment of nausea, anxiety, drowsiness, tiredness, and appetite; but not for pain, depression, 
shortness of breath, or overall well·being, The nurses demonstrated significant agreement wilh the 
patient on the perception of nausea only. 
Merging the nine reported similar studies on symptom agreement between patient and family with 
the present study there emerges no consistent evidence on agreement for pain, shortness of breath, 
well·being, anxiety, and appetite; while there is good evidence to suggest agreement on nausea, 
depression, tiredness, and drowsiness. 
Similarly, reviewing the two studies involving cancer patients and nurses, there emerged no 
consistent evidence on the agreement for pain, nausea, tiredness, drowsiness, or appetite. While the 
previous studies did not assess shortness of breath, anxiety, and well·being, there was over .-estimation 
by the nurses on the patient' s ratings of depression. 
CONCLUSIONS: 
1) 
2) 
3) 
4) 
Family members agreed with the patients in their perceptions of five out oi 
nine cancer-related symptoms: nausea, anxiety, drowsiness, tiredness, and 
appetite. 
Family members did not agree with the patients on the symptoms of: pain, 
depression, shortness of breath, and well-being. 
Nurses agreed with the patients in their perceptions of one out of nine 
(nausea) cancer related symptoms. 
Family members were closer in their perceptions of the cancer patients' 
symptoms than were the nurses. 
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CHAPTER I 
INTRODUCTION AND REVIEW OF THE LITERATURE 
1.1 INTRODUCTION 
Palliative, or end-of-life care; as described by Singer and MacDonald 
in a 1996 review of bioethics for clinicians1; contains 3 main 
elements: control of pain and other symptoms, discussions concerning 
the use of life-sustaining treatments, and support of those who are 
dying and their families. This 3-part framework was developed as a 
guide for physicians caring for the families and patients suffering from 
advanced cancer. The World Health Organization offers the following 
definition of palliative care: 'The active total care of patients whose 
disease is not responsive to curative treatment. Control of pain , of 
other symptoms, and of psychological, social and spiritual problems, 
is paramount. The goal of palliative care is achievement of the best 
quality of life for patients and their families. Many aspeds of palliative 
care are also applicable earlier in the course of the illness in 
conjunction with anticancer treatment. '2 
The burden of cancer-related suffering experienced by both patient and 
family is extensive. The incidence of cancer in Canada is rising, 
according to the National Cancer Institute of Canada1, and is 
attributable mostly to the increasing age structure of the population. 
The risk of developing cancer increases with increasing age for both 
individuals and populations. In Canada there were approximately 
129,000 new cases and 61,800 deaths from cancer in 1996. The 
symptoms of cancer are distressing with the most common symptoms 
listed in Table I. The prevalence, severity and clinical importance of 
these symptoms were reported in two studies done by a group of 
palliative care nurses and physicians working out of Cleveland, 
Ohio",'. This group prospedively reviewed consecutive cancer 
patients who were referred to their service: one hundred, reported in 
1991, were assessed for the presence of symptoms; and 1000, reported 
in 1995, were assessed for severity of symptoms. The authors discuss 
the paucity of research in this area. 
1.2 BACKGROUND 
Family members, besides experiencing their own issues during the 
cancer experience, suffer vicariously the distress of the cancer patient 
as together they live through this all too often, progressive and fatal 
illness. In 1994 a palliative care research group in Manitoba' studied 
64 consecutive, consenting cancer in-patients and their families using 
a validated symptom distress scale. The authors found that family 
caregivers experience health effects, most notably deteriorations of 
mental health status and cognitive function, during the illness and after 
the death of their loved one. The authors note further that the physical 
burden of providing care and support to the ill patient also adds to the 
family stress. Using a questionnaire that was mailed out to 65 bereaved 
spouse care givers of recently deceased cancer patients, a nursing 
research group working out of California' in 1992, found, in the 38 
respondents, that the spouses felt a lack of control over what was 
happening to the cancer patient and that although physical care giving 
was difficult at the time, on later reflection the most distress 
experienced by the family members was related to standing by or 
observing the deterioration of the cancer patient. 
As the illness of cancer advances, and the number and intensity of 
symptoms increase; physicians may hear, either from the patient's 
nurse, during daily care discussions; or from the family members, 
during family meetings; diverse impressions about the patient's 
symptoms. As the patient becomes sicker and less able to 
communicate, family members and the nurses caring for the patient 
have, in the experience of the author, an increasing role in reporting 
on the patient's condition. 
TABLE I: PREVALENCE AND SEVERITY OF 
SYMPTOMS IN ADVANCED CANCER: 
CLEVELAND, OHIO 1991 and 1995 
SYMPTOM PERCENT PERCENT OF THOSE PATIENTS 
PREVALENCE W HO SUFFERED THE SYMPTOM 
1991 AND REPORTED IT AS SEVERE 
1995 
Pain 89 87 
Weight Loss 58 44 
Anorexia 55 67 
Dyspnoea 41 46 
Fatigue 40 70 
Early Satiety 40 75 
Constipation 40 60 
Weakness 36 70 
Lethargy 32 78 
Nausea 32 66 
Depression 31 71 
Sleep Problem 28 50 
Taste Change 26 77 
Vomiting 25 72 
Dry Mouth n/a 27 
Cough n/a 12 
Anxiety n/a 11 
Edema n/a 11 
ource: Curt1s eta. , and Donnelly et al. 
1.3 RATIONALE AND OBJECTIVES OF STUDY 
As a physician working in the field of Palliative Care, the author has 
been in situations where the patient reports one set and intensity of 
symptoms while the nurse reports another and the family members 
offer up still another. 
When a distressed family member reports that the patient's symptoms 
have worsened the physician may either accept this information as fact, 
and act to assess and relieve the patient's current symptoms, or view 
the family observations as reflecting the family member's own distress 
and offer supportive statements about how as much as possible is 
already being done to provide comfort to the patient. The present 
study was undertaken because little is known about how close the 
ratings of the family members and hospital-based nurses are to those 
of the patients in regards to symptoms experienced. 
1.4 OVERVIEW OF THESIS 
What literature exists on the subjects of: symptom prevalence in 
advanced cancer, family perception of cancer symptoms, and nurse 
perception of these symptoms will be reviewed. What literature is 
available to validate the nine 100 mm visual analogue scales (VAS) of 
the Edmonton Symptom Assessment System IESAS), an existing method 
of assessing and recording cancer symptoms, wi11 be discussed. Finally, 
an observational study of 100 cancer in-patients, their family members, 
and the nurses providing their care, using the ESAS to rate the 
symptoms suffered by the cancer patients, will be reported. The 
primary statistical analyses of the ensuing data will be to calculate 
Cohen's Kappa (a measure of agreement between two observers rating 
the same set of symptoms) and will use the patients' ratings of their 
symptoms as the 'gold standard' against which the ratings of the family 
members and the nurses will be judged. 
1.5 OBJECTIVES 
The objects of this descriptive study were: (1) to identify the intensity 
of nine cancer-related symptoms, as rated by hospitalized cancer 
patients, 2) to determine the extent of agreement between the symptom 
ratings of these cancer patients and the ratings of their family members 
and those of the nurses providing the bedside care, (3) to determine 
over-estimation or under-estimation of these symptoms, if the family 
members and the nurses did not agree with the patient, and (4) to 
determine whether the nurses or the family members agree more 
closely with the patients' ratings on these nine symptoms. The nine 
symptoms are those rated using the Edmonton Symptom Assessment 
System (see section 2.6, page 1 8). 
1.6 HYPOTHESES 
Nurses either under-estimate or over-estimate somewhat their patients' 
symptoms, while family members over-estimate greatly the patients' 
symptoms. Nurses agree w ith the patients' assessment of the symptoms 
more closely than do the patients' family members. 
1.7 REVIEW OF LITERATURE: OVERVIEW OF CONCORDANCE 
OF PERCEPTIONS OF CANCER RELATED SYMPTOMS BY 
PATIENT, FAMILY MEMBER, AND NURSE 
Published differences (or agreement) between patient, family member, 
and nurse in the perceptions of the intensity and prevalence of cancer-
related symptoms will be reviewed. Using WinSpirs 2.1. a Medline 
search was undertaken with the MESH headings of Neoplasms, Family, 
and Caregivers. One-hundred-thirty-seven such articles were found. 
Those articles that were of the anecdotal or clinical impressions 
variety, related to the genetic inheritance of cancer, or concerning 
cancer screening were not reviewed. Twelve articles in English 
reporting on observational surveys are reviewed. Eleven articles are 
listed in Table II because two of the articles concern the same cohort 
of subjects. 
TABLE II: 
Study 
Lobchuck 
et al 
Ferrell 
1995 
Curtis and 
Fernsler 
Clipp and 
George 
O'Brien 
and Francis 
Madison 
and Wilkie 
Yeager et al 
Miaskowski 
et al 
Ferrell 
1991 
Holmes and 
Eburn 
Grossman 
et al 
tudy reters tot 
STUDIES ON THE RELATIONSHIP BETWEEN 
CANCER PATIENTS' PERCEPTIONS OF THEIR 
SYMPTOMS AND THE PERCEPTIONS OF THEIR 
FAMILY MEMBERS AND NURSES 
Symptom Relation- Number Estimation 
Assessed ship to of Compared 
Patient Subjects With Pt. 
Multiple Family 37 Over 
Multiple Family so Over 
Pain and Family 23 Under 
Multiple Agree 
Pain and Family 30 Agree 
Depression 30 Over 
Pain Family 42 Agree 
Pain Family 18 Over 
Pain Family 86 Over 
Pain Family 78 Over 
Pain Family as Over 
Multiple Nurse 53 Over 
Pain Nurse 103 Under 
e pnnc1pal author at those studies reported 1n Chapter 
Table II shows the results of this search listing the authors, number of 
subjects, whether nurses or family members were involved, and what 
type of agreement was found. 
As can be seen in Table II, seven of the studies reported that family 
members over-estimated the patients' symptoms; while three studies 
found either under-estimation, or agreement, or no difference in 
symptom ratings. One study reported that nurses under-estimated the 
patients' symptoms while another described over-estimation of the 
patients' symptom ratings. 
1.7.1 PERCEPTIONS OF PATIENT AND NURSE ABOUT CANCER 
RELATED PAIN 
While studying consecutive in-patients with solid tumour cancers in 
Baltimore in 1991, Grossman et al, 8 had both patient and nurse use 
the 100 mm visual analogue scale IV AS) to measure the patients' mean 
pain experiences since admission to hospital. A total of 146 patients 
were admitted during the study period resulting in 103 study subjects; 
of the remaining: three refused, 14 failed a test of mental competence, 
20 were too ill or discharged before being evaluated, while 6 had 
inadequate data collected. The nurses underestimated the patients' 
pain: patient mean score 34 mm, nurse mean score 24 mm. The 
Pearson correlation coefficient showed a fair relationship between 
patient and nurse ratings that was statistically significant (r - 0.46, p 
< 0.0001). For those patients who ranked their pain as low (VAS 0-
20 mm) the percent agreement between patient and nurse was 82% , 
for mild pain IV AS 30- 60 mm) the agreement was 51%, while for 
severe pain IV AS 70- 1 00 mml the agreement was 7"/o. The sub-group 
correlations and percent agreement were not statistically significant. 
Although describing little more than trends in percentage agreement 
(see methods section for a discussion of percent agreement) and a 
correlation for the whole sample but not for the sub-groups, this paper 
has been quoted in a reference text9 as demonstrating a poor 
agreement between nurses and patients at the higher levels of pain and 
better agreement at lower pain intensities. 
1.7.2 PERCEPTIONS OF PATIENT AND FAMILY ABOUT CANCER 
RELATED PAIN 
O'Brien and Francis10, working in two counties of Washington state 
in 1982, wrote an oft-quoted paper on family members' perceptions of 
the cancer patients' pain experiences. Their subjects, 42 out-patients 
with cancer (of either lung, pancreas, prostate or uterus) and their next 
of kin, were selected from a sample of 80 cancer patients, however the 
sampling methods were not described. Pain was measured using a five 
point linear adjectival pain scale and the McGill Pain Questionnaire (a 
descriptive scale). Using the kappa statistic these authors concluded 
that the family members showed moderate agreement with the patient 
(k - 0.37 p < 0.0011 on mean pain ratings over the past week, poor 
agreement with the patient on the immediate presence of pain (k -
0.22, p - 0.13), and no agreement on medications taken or on 
location of the pain. The family members over-estimated the patients' 
pain. The Kappa statistic was an appropriate indicator of agreement 
beyond chance, the measurement instrument has been well validated, 
however the poorly described sampling method weakened the study 
In 1995 Yeager and colleagues", working within the Oncology 
Nursing Research Network studied cancer out-patients and their family 
members in 16 sites: 1 5 in California and one in Montana. The 
subjects, selected by convenience, were 86 patients w ith cancer·related 
pain, 43% of the patients had cancer of either the breast, lung or colon 
while 53% had "other", not further defined, cancers. These authors 
used a series of 100 mm VAS to rate the patients' pain and calculated 
t test scores to deted any significant differences. Family members rated 
the pain higher (mean score 51.2 mm) than the patients (mean score 
41.7 mm) did themselves (t - 2.2, p - 0.031. 
As part of a larger 1996 study, which appeared to be an extension of 
the above study, on family coping; Maiskowski" and colleagues in 
California reported on the pain perception of 78 cancer patient/family 
dyads selected by convenience. The patients were recruited from 16 
out-patient oncology clinics: 15 in California and one in Montana. 
Unfortunately neither the selection process nor the nature of the cancer 
was reported. The patients' pain was rated using a 100 mm VAS. The 
authors found that 30% of the dyads were congruent, while 18% of 
family members underestimated and 52"/o overestimated the patient's 
pain. The strength of the conclusions from the last two studies 
concerning agreement between patient and family members on pain 
perceptions is weakened by the non-random sample and the use of 
statistical tests that assess difference rather than agreement, and the use 
of the statistically weaker test of percent agreement. 
Still out of California, Ferrell13 et al, reported in 1991 on their study 
of 60 in-patients and 25 out-patients with cancer and their closest 
family members. Their convenience sample was chosen from patients 
attending either a community hospital, a national cancer centre, or a 
home hospice programme. Although the cancer diagnoses were not 
given; the length of the illness, the analgesics used, and the nature of 
the family relationship were well described. Eighty-five percent of the 
family members lived with the patient and 63 "1. were spouses. Pain 
was measured using the 100 mm VAS; the family members mean score 
was 69.92 (SD - 28.87) while the patients' mean score was 45.47 (SD 
- 28.42). Although the investigators did not apply any statistical tests 
to these results, the family members appeared to over-estimate the 
patients' pain. 
As an extension of the study above, the same group, Ferrell et al", 
compared pain perceptions of the 85 cancer patients and their family 
members in three settings: community hospital (patient mean score 
51.8, family mean score 77.8), hospice (patient 35.1 , family 66.2), and 
a cancer centre (patient 52.8, family 67.0). The authors applied 
statistical tests to the difference between patients between sites but not 
between patient and family. Still these data appear to indicate that 
family members over-estimate patients' perceptions of pain. In both of 
these last two studies the sample was not random and the statistical 
tests were not applied to the difference between patient and family 
member; so any conclusions about agreement between patient and 
family must be drawn with caution. 
In 1994 Madison and Wilkie" studied a convenience sample of 18 
out-patients with lung cancer and their closest family members in 
Seattle, Washington. Pain was measured by the McGiii-Melzack Pain 
Questionnaire and the 100 mm VAS. The authors used Spearman 's 
Rank Order Correlation coefficient (rho) to compare the patients' pain 
as rated by the two groups. Although no correlation was found for total 
pain ratings (rho - 0.27, p N/S), the affective component of the pain 
scale showed a strong correlation (rho - 0.55 p < 0.05) between the 
patients and family members. The authors reported that 22% of 
families correctly estimated, 22% under-estimated, while 56% over-
estimated the patients' pain ratings. The use of the rho to test for 
correlations between patients' and family members' pain ratings is 
appropriate, as used in this study, while percent agreement points only 
to a trend. This study, with its low number of subjects and large 
number of statistical tests, indicates there may be some concordance 
between ratings offered by patient and family. 
1.17.3 SUMMARY 
Of the 5 studies (six publications: the two Ferrell groups published 
twice on the same study) reported on above, none of the authors used 
a random or consecutive sampling method, 4 studies used a 
convenience sample while the fifth didn't report the sampling method. 
All authors reported on the inclusion criteria of pain and whether their 
subjects were in-patients or out-patients. Two studies reported on the 
type of malignancies involved while the remaining 3 noted only that 
the subjects were cancer patients. All 5 of the above studies dipped 
into a mixed bag of family members with 60% to 78"/o being spouses 
and the rest being offspring or parents depending on the age of the 
study patients. 
One of the authors, appropriately, calculated Cohen's kappa while 
another, also appropriately, used Spearman's rho to evaluate how 
closely the family members agree or correlate in their perceptions of 
the cancer patient's suffering. The other 3 authors used the t-test to 
assess differences in perceptions, which seems inappropriate as a lack 
of difference does not equal agreement or correlation. Over-all the data 
reviewed indicate that family members tend to over-estimate the 
patient's pain. 
The evidence from the one reviewed study that involved nurses 
indicates that they under-estimate the patients' pain. 
1.17.4 PERCEPTIONS OF PATIENT AND NURSES ABOUT 
MULTIPLE CANCER SYMPTOMS 
All of the reviewed studies reported on the symptom of pain, six 
studies assessed only pain, one study assessed pain and depression, 
leaving four studies that measured perception, by patient and nurse or 
by patient and family of many of the symptoms listed in Table I. 
The first was conducted by Holmes and Eburn in Surrey, England and 
published in 1989". Fifty-three cancer patients (not further described! 
and the nurses who were caring for them assessed the patients' 
symptoms using a series of 1 00 mm Visual Analogue Scales within a 
modified McCorkle & Young Symptom Distress Scale. The nurses over-
estimated the patients' overall symptoms. The authors used a t-test to 
evaluate the statistical significance of any differences in perceptions 
and found that for pain, nausea, appetite, sleep, mood and 
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concentration there were statistically significant differences and that the 
nurses over-estimated these six symptoms. For the symptoms of 
mobility, diarrhoea, constipation, tiredness, and appearance the nurses 
and their patients did not demonstrate statistically significant 
differences in perceptions. No tests of agreement or correlation were 
performed. There was no description of the sampling method, or the 
hospital setting, nor were the raw symptom scores reported. As this 
study was not well described the nature of the conclusions may not be 
generally applicable to clinical situations. 
1.17.5 PERCEPTIONS OF PATIENT AND FAMILY ABOUT 
MULTIPLE CANCER SYMPTOMS 
The second multi-symptom study was conducted in Winnipeg, by 
Lobchuk et al, between August 1994 and March 1995". The 37 (out 
of 62 eligible) subjects were lung cancer out-patients and their main 
family caregivers recruited consecutively from two palliative care 
programs and three chemotherapy out-patient programs. The authors 
administered the unmodified McCorkle & Young Symptom Distress 
Scale, which measures symptoms using a five point Likert Scale. The 
authors used Cohen's kappa to assess binomial agreement between 
the family and patient ratings, using 3 out of 5 as the cut-off point. 
Statistically significant agreement (p < 0.05) was found for fatigue (k 
- 0.63), appetite (k - 0.60}, pain frequency (k - 0.55}, cough (k -
0.52}, nausea frequency (k - 0.47}, insomnia (k - 0.43}, breathing (k 
- 0.41), and outlook (k - 0.33}. Symptoms on which no agreement 
was found (kappa values less than 0.31 and non significant p values} 
were: pain intensity, appearance, concentration, nausea intensity and 
constipation. The family caregivers over-estimated the latter five 
symptoms. This study appeared to be well done: the sampling method 
was appropriate, the subjects were well described, the raw scores were 
given, and the kappa statistic was used to assess agreement. This study 
showed that the families agreed with the lung cancer patient on 8 of 
the 13 symptoms assessed. 
While studying the impact of a cancer pain education program on 50 
cancer out-patients and their families, Ferrell et al 18, in 1995, used 
the 100 mm VAS to assess pain and a well validated quality of life 
index to assess other symptoms. The patients were all over 60 years of 
age and were recruited non-randomly from two cancer treating 
institutions in California using pharmacy and oncology clinic records 
that identified patients receiving analgesics. The cancer diagnoses, 
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analgesic use, pain sites, and spousal relationships were well 
described. The authors used at test to compare mean symptom ratings 
and found that family members significantly (p < 0.01) over-<!stimated 
the following symptoms: concentration, appetite, tiredness, pain, 
strength, worry, and usefulness. No differences were found concerning 
sleep, affection given/received, disease adjustment, life enjoyment, 
sense of control, support, and ability to perform leisure activities. As 
the sample was not random and the statistical tests used evaluated 
differences in symptom ratings rather than agreement, the data, from 
this study, to indicate levels of agreement on symptom assessment, are 
not strong. 
In 1991 Clipp and George" in North Carolina reported on their use 
of correlational computations (not further defined) and percent 
agreement to study the symptom perceptions of thirty cancer out· 
patients and their spouses. The sample was randomly selected and 
stratified to include equal numbers of male and female patients with 
either cancer of the lung or bowel. All patients were married and living 
with their spouse. The authors report that for pain the r - 0.55, with 
spouses under-estimating somewhat. For depression the r - 0.53, with 
the spouses over-estimating somewhat. No tests of significance were 
applied to these data, although this study appeared to be well done 
othei"Nise, offering a strong case for moderate concordance between 
patient and spouse on the cancer-related symptoms of pain and 
depression. 
Curtis and Fernsler0, working out of home hospice programs in 
Delaware in 1989, studied a convenience sample of 23 cancer 
patient\family member dyads. The patients were all suffering from 
cancer but the diagnoses were not further defined. Spouses comprised 
56% of the family members. Length of time in the hospice program 
varied from 7 to 85 days and the ages of the patients ranged from 41 
to 84 years. Multiple symptoms were assessed using a series of 100 
mm VAS scales. Pain scores were different (statistical significance of p 
< 0.05) between patient (75.9) and family (63). The authors, using the 
t test found no statistical differences for the following symptoms: 
nausea, appetite, strength, work, sleep, fun, satisfaction, and quality of 
life. Again, lack of difference does not equal agreement, and because 
of the non random sampling method used the conclusions offered by 
these authors may not be applicable to a wider population. 
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1.17.6 SUMMARY 
In the one study on the subject of nurses' and patients' perceptions of 
multiple cancer-related symptoms the nurses over-estimated: pain, 
nausea, appetite, sleep, mood, and concentration. No differences were 
found for: mobility, diarrhoea, constipation, tiredness and appearance. 
These findings are not more widely generizable because of the small 
numbers of subjects, the sampling methods, and the statistical 
proceedures used. 
Two of the four studies involving patients and family members used 
the t test to test for differences between multiple symptom ratings. 
Within one of these studies the family members over-estimated: 
appetite, pain, strength, usefulness, and tiredness; while no differences 
were found for: sleep, affection, adjustment, control, support, and 
leisure activities. Within the second of these studies, the family under-
estimated the patients' pain while no differences were found for 
nausea, appetite, strength, work, sleep, fun, satisfaction, and quality of 
life. A third study used correlations to show that the family members' 
ratings of pain and depression correlated with the patients' perceptions, 
while the fourth study, using Cohen's Kappa to calculate agreement, 
found over-estimation by the family members for: pain intensity, 
concentration, nausea intensity, appearance, and constipation; and 
agreement with the patient on fatigue, appetite, pain frequency, cough, 
nausea frequency, insomnia, dyspnoea. There appears to be no clear 
constellation of symptoms on which patient and family agree. Overall, 
the family members tended to over-estimate the patients' symptoms. 
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CHAPTER II 
DESIGN, CONDUCT, AND ANALYTIC PLAN OF THE STUDY 
2.1 INTRODUCTION 
This descriptive study compared the perceptions of nine cancer-related 
symptoms, experienced by in-patients receiving cancer therapy, with 
the perceptions of the closest available family member and the nurse 
providing the bedside care. One hundred consecutive eligible patient 
admissions, providing the patient-family-nurse triads, were evaluated 
between September, 1997 and February, 1998 on three wards within 
the Health Care Corporation of St. John's. 
2.2 ETHICAL CONSIDERATIONS 
Eleven studies, reviewed in Chapter I, assessed the relationship 
between patient and family or between patient and nurse concerning 
the perceptions of cancer-related symptoms. As no dear consensus has 
been reached on the nature of these relationships it is ethical to study 
the matter further. 
The author was the sole investigator and personally obtained the 
consent of the patient, family, and nurse subjects. All subjects were 
informed of the voluntary nature of their participation. Confidentiality 
was ensured by the investigator who stored all data in a secure place 
well away from the hospitals. 
Recruitment methods, consent procedures, and measures to protect 
confidentiality will be discussed fully below. 
2.2.1 HUMAN INVESTIGATION COMMITTEE 
The Human Investigation Committee of Memorial University of 
Newfoundland, Dr. B. Younghusband, Chair, approved this study on 
September 11 , 1997. See appendix V for a copy of the approval letter. 
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2.2.2 HOSPITAL APPROVAL 
The Medical Advisory Committee of the Health Care Corporation of St. 
John's recommended and the Board of Directors of the corporation 
formally approved this study's commencement in October of 1997. 
Dr. E Parsons, Vice-President of Medical Services for the corporation 
was able to give conditional approval September 12, 1997 and 
Appendix VI shows a copy of his letter of approval. 
The investigator met with the nurse managers of the Surgical, Palliative 
Care and Oncology programs of the Health Care Corporation of St. 
John'sto explain the study and answer any questions, and held similar 
discussions with the chief of surgery at the St. Clare's site, the 
oncologists and haematologists at the Health Science Centre site, and 
the medical director of the Palliative Care Program. 
None of the above managers/ directors were involved in the 
recruitment of subjects, collection of data, analysis of results, or 
subsequent write-up. 
2.3 STUDY SUBJECTS 
Figure I shows the flow chart summarizing the patient selection 
process. Please see next page for Figure I 
2.3.1 INCLUSION CRITERIA 
Patients were eligible to enter this study if they were: well enough to 
participate, suffering from a malignancy, admitted to hospital because 
of this malignancy, and had their closest relative available for 
interview. The closest relative was recruited, in descending order of 
priority, as per the next of kin legislation for Newfoundland: spouse, 
adult child, parent, sibling, grandchild, cousin, close friend. In 
situations of doubt the patient was asked to identify the person most 
appropriate. 
Subjects were recruited from three hospital wards within the facilities 
of the Health Care Corporation of St. John's, Newfoundland: 4 North 
A at the Health Science Complex, the provincial referral site for 
oncology and haematology patients; 6 East at St. Clare's Hospital, a 
regional centre for cancer related surgery; and the Palliative Care Unit, 
a regional referral centre. 
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STUDY SUBJECT RECRUITMENT FLOW CHART 
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(8) 
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2.3.2 EXCLUSION CRITERIA 
Patients were excluded from this study if they: refused the solicitation 
to participate from either the charge nurse or the investigator, were 
confused (as assessed by the charge nurse's clinical judgement during 
usual daily care or by the investigator after the administration of a short 
but formal test of mental status}, were incapacitated due to severity of 
symptoms (as assessed by the charge nurse), or had no family members 
available or willing to participate. 
2.4 RECRUITMENT OF PATIENT AND FAMILY 
The procedure for recruiting subjects was as follows: the charge nurse 
would approach eligible patients after routine daily rounds and assess 
both severity of distress and mental status based on the patient's 
behaviour over the past 24 hours. These bedside assessments were the 
clinical judgements of one of the five senior, experienced nurses 
whose job it is to attend daily ward rounds as part of the medical 
team, and to supervise the nurses providing the bedside care. Patients 
were approached as soon as possible after admission. Those patients 
obviously confused, somnolent, or in great distress were not 
approached. If the patient appeared alert and well enough to talk the 
nurse would ask the following question "Would you be wil ling to talk 
to a medical researcher who is doing a study on the symptoms of 
people in hospital?" 
If the patient agreed to such a meeting the investigator would approach 
the patient to explain the study procedure further and return, if the 
patient agreed, when the closest relative was visiting the hospital. At 
that time the investigator would further explain the data collection 
process, ask for and answer any questions, obtain verbal consent from 
all parties, and have both patient and family member sign consent 
forms. 
Any patient consenting to the study who seemed cognitively intad to 
the charge nurse but was over 60 years of age, appeared confused to 
the investigator, or was suffering from brain involvement as a 
consequence of their disease was formally tested, by the investigator, 
for mental status. The test used was the Canadian Mental Status 
Questionnaire2 \ a ten item test which was has a test-retest correlation 
of 0.98, a sensitivity of 0.69, and a specificity of 0.94 for moderate and 
severe cognitive impairment when using a cut-off score of 7 out of 10. 
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Verbal consent to administer this test was obtained from the patient 
before proceeding. Patients who scored less than 7 out of 10 were 
excluded from the study. No patients deemed confused by the charge 
nurse, and therefore excluded from the study, were formally tested for 
mental status. 
Competence of the patient to engage in this study was confirmed by 
one of the patient's doctors, usually a member of the house staff. If, in 
the opinion of the doctor, the patient was competent to understand the 
voluntary nature of such research, the doctor would indicate same by 
signing a statement to that effect on the patient's consent form. No 
patients who scored 7 out of 1 0 or greater on formal testing were 
deemed incompetent by their dodors. 
2.5 RECRUITMENT AND TRAINING OF NURSES 
The nurses who participated as subjeds in this study were actively 
involved in the bedside care of the patient-subjects. Sixty-four such 
nurses underwent a 10 to 15 minute training session on the 
completion of the ESAS and signed consent forms indicating their 
understanding of their role in the study and the voluntary nature of 
their participation. These nurses were told the study's aim was to 
compare their ratings of nine cancer-related symptoms suffered by their 
patient with the patient 's own ratings. They were told that such 
assessments don't always agree but were not told whether this 
disagreement was in over- or under-estimation. The investigator 
reviewed the method of rating the patient's symptoms using the ESAS 
just prior to the nurse completing it. 
The five charge nurses (three from 4 NA, one each from 6 E and PCU), 
were responsible for the recruitment of the patient-subjects, and were 
further instructed in ways of approaching patients as potential subjects 
to maximize cooperation while proteding the right of any patient to 
refuse participation. These nurses assessed confusion and severity of 
illness based on their clinical experience and expertise. 
2.6 THE EDMONTON SYMPTOM ASSESSMENT SYSTEM (ESAS) 
Those who work with patients in or nearing the uncomfortable phase 
of the cancer experience are always endeavouring to develop better 
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ways to assess their patient's symptoms of distress. Symptom evaluation 
forms, such as the ESAS, have been developed to help in the 
evaluation and documentation of these symptoms. Appendix I shows 
the adual form containing the VAS scales which are used to rate the 
nine symptoms assessed by the ESAS. 
Of the 11 studies listed in Table II (page 61, eight used the Visual 
Analogue Scale (VAS) to measure symptom ratings, 2 used adjedival 
scales, while one used a Likert scale. The present study involves 
subjeds similar to those in the studies listed in Table II so, if 
convention were to be followed, the VAS would be the apparent 
choice of symptom measurement instrument. 
In 1990 Bruera et al" reported on their development and clinical 
usefulness of the ESAS. The authors, using t tests on the mean daily 
total ESAS scores of 101 consecutive admissions to their palliative care 
unit, reported statistically significant improvement in symptom ratings 
{mean distress score 410+/-95 on day one after admission, versus 
362+/- 83 day five, p < 0.01) that coincided with clinically observed 
improvement in the patient's comfort. The form is easy to understand 
and quick to complete. This earlier version listed eight symptoms, 
more recent versions have added a scale for shortness of breath. 
The ESAS is comprised of nine visual analogue scales (VAS) one for 
each of the common cancer-related symptoms: pain, nausea, 
depression, anxiety, shortness of breath, tiredness, drowsiness, appetite, 
and overall well being. The evidence to support the use of the VAS to 
measure these nine symptoms is reviewed and evaluated in Chapter Ill. 
The specific sensitivity and specificity of the VAS could not be found 
in the literature; nor could the sensitivity and specificity of the ESAS, 
as a whole, be found. For the five symptoms of pain, nausea, shortness 
of breath, anxiety, and depression, the VAS appears as valid and 
reliable as other instruments available (see Chapter 1111. For the 
remaining four symptoms: tiredness, well being, drowsiness, and 
appetite; the validity and reliability of the VAS can only be inferred. 
Holmes and Eburn", using the 11 VAS measures of the McCorkle and 
Young Symptom Distress Scale, calculated the reliability of the whole 
distress scale for 53 cancer patients and their nurses. The coefficient 
alpha of the nurses' data was 0.81 and 0.97 for the patients'. This 
scale, uses a series of 100 mm VAS as does the ESAS, making it similar 
enough to allow similar conclusions about the internal reliability of the 
ESAS. 
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None of the other multiple-symptom rating instruments used by the 
authors listed in Table II (page 6) were similar enough to the ESAS to 
permit comparisons of validity and reliability with these instruments. 
Because of its simplicity, Canadian genesis, and its anticipated regular 
use with the patients referred to the palliative care service in St. John's, 
the ESAS was chosen as the symptom assessment tool for the present 
study. In the present study the subjects were asked to complete a set 
of nine VAS measures. Because the subjects were suffering from cancer 
of various types and at differing stages of their illnesses the means and 
standard deviations reported in the literature may be unsuitable for use 
in the comparative analysis of the data. 
In a review of the use of the VAS (Chapter Ill) a difference of 10 mm 
or more between one rating score and another of a particular symptom 
is, in most of the studies using the 100 mm VAS, the standard 
clinically significant difference within that symptom. Similarly a 
difference between patient and care-giver ratings for any symptom of 
10 mm or more is used as a significant difference by most of the 
authors who report on the use of the VAS (see Chapter Ill). 
2.7 DATA COLLECTION 
The patient and family member were asked to complete the ESAS 
independently from each other (usually the relative went first). The 
investigator was present to answer questions, ensure that the subjects' 
ratings were independent from each other, read the words on the form 
if the patient couldn' t read, and physically assist those too weak to 
complete the form. In all cases the patient and family member 
completed the ESAS at the same time. Given the time issues 
concerning recruitment and family visiting the data colledion took 
place during the afternoons. As such the family would have had the 
opportunity to sit and chat with the patient before completing the 
ESAS. 
The investigator would then locate the patient's primary nurse (usually 
within five minutes) and have her complete the ESAS. All subjects in 
the patient/family/nurse triad completed the ESAS to rate the patient's 
symptoms for a similar point in time. The patient's nurse would 
complete the ESAS based on the regular assessments made throughout 
the day. As most of the data collection took place in the afternoon or 
early evening most of the nurses involved in this study had the 
opportunity to assess the patient before completing the ESAS. 
20 
Subjects were asked to complete the ESAS once only for each patient. 
Patients who were subjects during one admission were not included 
if they had a subsequent admission during the study period. 
The subject's age and diagnosis were obtained verbally from the 
patient or the nurse while the family member's relationship and 
location of residence relative to the patient was obtained from either 
the patient or family member. The investigator did not review the 
patient's chart. 
2.8 DATA MANAGEMENT 
Each subject triad was given a study number with which the ESAS data 
sheets were coded, accompanied by the appropriate descriptive term 
(patient, family, nurse). The identity of the nurse was not recorded on 
the data sheets or anywhere else. The patient's age, ward location, 
diagnosis, mental status score (as appropriate), gender; the fam ily 
member's relationship to the patient, and location of residence were 
recorded on the patient data collection form, a likeness of which is 
shown in Figure II. 
A research log book was kept on each ward into which the charge 
nurse would record the names of patients with cancer admitted to the 
ward (eligible subjects). The research log book recorded those who 
agreed to meet the investigator, those who refused the approach of the 
charge nurse; those who were, in the opinion of the charge nurse, too 
ill or confused to take part; those who refused the approach of the 
investigator to take part, and those who failed the formal test of mental 
status. Unfortunately no record was kept to distinguish between those 
patients who were too ill to be approached, had no family members 
available, or were discharged before the charge nurse could approach 
them. 
The investigator scored each VAS of each ESAS for each subject triad 
by measuring the 100 mm VAS from the left. These scores were 
recorded in a data book and subsequently entered into the SPSS 
package for personal computers. The consent forms completed by the 
patients, family members, and nurses; the ESAS data sheets of each 
member of the triad; the ward log books, data book, and personal 
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computer were stored securely at the home of the investigator. 
FIGURE II: PATIENT DATA COLLECTION FORM 
Patient Name 
Study Number 
Ward 4NA 
6E 
PCU 
Age 
Gender Male 
Female 
Diagnosis 
Family Member Spouse 
Child 
Parent 
Sibling 
Other Relative 
Friend 
Residence of Same House 
Family Member Same City 
in Relation to the Patient Distant 
Mental Status Score 
(as appropriate) 
2.9 QUALITY CONTROL OF THE DATA 
Quality control was assessed by a second investigator UH) measuring 
and scoring a random sample of 10% (270 VAS scales) of the total data 
set and comparing these scores with the primary investigator's (BE) 
measurements and scores. 
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Agreement between these two investigators' measurements was 
assessed using the Kappa statistic. 
2.10 DATA ANALYSIS 
The aim of the present study was to assess agreement been patient and 
family and between patient and nurse on the nine symptoms assessed 
by the ESAS. Cohen's Kappa, a statistical test of agreement between 
two judges measuring the same phenomena, will be applied to the 
symptom ratings offered by each member of the subject triad. Scaner 
diagrams, to show what linear relationships exist between patient and 
nurse and between patient and family, will be created. 
The descriptive statistics of frequency, means, and standard deviations; 
as well as Spearman's Rank Order Correlations and t tests will be 
applied to the ESAS symptom data in order to compare the present 
study's findings with those of the authors listed in Table II. 
Demographic data will be presented in tables giving frequencies as 
appropriate. 
No comparisons of agreement between patient and family member 
within the different sub-sets of family members (ie. spouse, adult child, 
sibling) or of their location of residence relative to the patient will be 
made because of the small numbers of subjects. For the same reason 
no such comparisons between the different nursing sub-groups (ward 
locations) will be made. 
Table II (page 6) shows the results of the concordance of symptom 
perception between cancer patients, their family members, and their 
nurses as reported in Chapter I. The symptoms assessed and the 
statistical methods used to evaluate correlation, association, or 
agreement are shown for the same studies in Table XIV (page 69) and 
discussed in Chapter V. 
Using standard texts of statistical methods23, 24 / 5 the test statistics 
used by the authors listed in Tables II and XIV, and the appropriate test 
statistics to be applied to the data of the present study will be 
discussed. 
2.10.1 CALCULATION OF THE t SCORE 
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The Student's t-test was developed by the statistician, William Gossett, 
working in Dublin and analyzes the difference between the mean 
scores of two sets of observations. 
As displayed in Table XIV the t-test is a commonly used statistic to 
assess the significance of any differences between the patient's 
symptoms as rated by each member of the study triad. The t score is 
calculated using the formula shown in Figure Ill. 
Figure Ill: Calculation of the t score. 
The t score 
S.E. for Unpaired Data: 
S.E. for Paired Data: 
X , - mean group 1 
t=(i; -X,)!S.E. 
X2 - mean group 2 
S.E. - standard error 
n - sample size 
51 - standard deviation 
group 1 
52 - standard deviation 
group 2 
S.E.=/[S~/(n- 1)] 
s, - standard deviation 
of difference between pairs 
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The computed t score is compared to a table of standard t scores and 
significance of the score is based on sample size. As the sample size 
approaches 30 the t distribution becomes normal. 
For the paired t-test the t score is calculated the same way except the 
standard error of the differences is derived by taking the difference 
between the two scores for each subject, computing the mean 
difference for the whole sample, squaring the differences between each 
score and the mean difference, dividing by the degrees of freedom 
(sample size minus one) and taking the square root. 
The difference between the t-test for unmatched subjects and the t-test 
for paired subjects is mathematical and has little to do with direct 
comparisons of two observations on the same individual. In the present 
study it is conceivable that the means of scores offered by the members 
of each triad might be close yet there be little actual agreement. 
The t-test tests the null hypothesis that the difference between the 
means is zero. If there were perfect agreement between each member 
of the triad the difference between the means would be zero and the 
null hypothesis would not be refuted. 
The paired t-test is the appropriate test statistic to test the significance 
of any differences between the nurses' and patients' ratings and 
between the family members' and patients' ratings. As some authors 
report on over or under-estimation of the care-giver ratings compared 
with the patient ratings, this test will be applied to the mean symptom 
scores of the 1 00 mm VAS scales of the raw data. 
The t-test is not the appropriate test statistic to assess agreement 
between raters because it tests for significance of difference between 
groups not for agreement. The inability to disprove difference does not 
necessarily prove agreement. 
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2.10.2 CALCULATION OF THE PEARSON CORRELATION 
COEFFICIENT 
The Pearson Product Motion Correlation Coefficient assesses the 
strength of the relationship between two sets of measurements at least 
one of which is independent. The r statistic is calculated by either of 
the two formulae shown in Figure IV. 
Figure IV. Calculation of the Pearson Product Moment 
Correlation Coefficient (r) 
r=}: (x-x)(y-y)l,l[}: (x-x)'"L (y-y)2] 
or 
x - observations 
of group 1 
y - observations 
of group 2 
r=,fi:£ squares(R)I(L squam(R) + L squares( E)]) 
R - regression 
E - error 
The significance of r is calculated thus: if the null hypothesis states 
that the probability that r - 0 the t statistic is used while if the null 
hypothesis states that r - some value other than zero the z distribution 
is used. 
Pearson's r has a range of -1 to + 1 the value sign indicating the 
direction of any relationship. Correlations from 0 to 0.25 indicate little 
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or no relationship, those between 0.25 and 0.50 indicate a moderate 
relationship, while those between 0.50 and 0.75, show a strong 
relationship, while those greater than 0.75 show a very strong 
relationship. 
Although this measure appears more acceptable than the t test in that 
the null hypotheses (that r - 0, or that r "' 0) can be tested, it does 
not take into account the pairing of observations in the present study. 
It is possible that disparity between ratings offeree by each member of 
the triads might result in acceptable Pearson product moment 
correlation coefficients yet not reflect actual agreement. 
2.10.3 CALCULATION OF SPEARMAN'S COEFFICIENT 
Spearman's Rank Order Coefficient (rho) is calculated between 
multiple pairs (ie nurse and patient) of observations (ie patient 's 
symptoms) by first ranking the scores for both sets of observations 
(usually by descending magnitude) and calculating the correlation 
coefficient between the rankings for each set of pairs. 
The pairing and the use of ranking instead of raw data are the main 
differences between Spearman's rho and Pearson's r. A distillation of 
Spearman's formula is shown in Figure V. 
FIGURE V: Calculation of Spearman's Rank Order Correlation 
Coefficient (rho) 
p =(l-6l(E d 2)1n(n '-n) 
n - sample size 
d - difference between 
ranks for each pair 
Again the range of rho is the same as for Pearson's r and the 
significance is calculated using the same conversions to tor z scores 
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and referring to the appropriate distribution tables. Although 
Spearman's rho is only 91 Ofo as efficient as Pearson' r in situations 
where the distribution of scores is truly normal, the rho statistic does 
test for correlation between pairs of observations. Spearman's rho can 
be used to measure inter-rater concordance when ordinal data has 
been collected. Because the difference in paired scores is used to 
calculate it, rho is an appropriate test statistic for the present study. 
2.10.4 CALCULATION OF COHEN'S KAPPA 
Percent agreement between observers' ratings of symptoms is an often 
used measure reported in the studies in Table XIV and ranges from 60fo 
to 82% depending on the symptom. There appears to be no 
consistency of percent agreement across these studies for the most 
commonly studied symptom of pain (range 10% to 82%). Percent 
agreement does not take into account either sample size or chance 
agreement. This test statistic will be used, with reservations, in this 
study to compare with the studies shown in Table XIV. 
Cohen's Kappa was described in 1964 and measures percent or 
proportion agreement taking chance agreement into consideration. 
Cohen's k is calculated as in Figure VI using percent agreement from 
a cross-tabulation table of the paired observer ratings and percent 
chance agreement calcu lated by adding the margins of each cell from 
this cross-tabulation table. 
FIGURE VI: Calculation of Cohen's Kappa (k) 
observed agreement - chance agreement 
1 - chance agreement 
The range of k is from -1 for perfect disagreement to + 1 for perfect 
agreement with 0 to 0.35 showing poor agreement, 0.35 to 0.5 
showing moderate agreement, 0.5 to 0.75 indicating strong agreement 
and 0.75 and above demonstrating very strong agreement. 
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2.11 CHOICE OF TEST STATISTIC 
Because the aim of this study is to measure agreement on perceptions 
of symptoms the kappa statistic will be used. Spearman's rho will also 
be calculated, on the whole raw data set, as a measure of correlation 
between pairs, and to amplify the Kappa results. Student's t-test will be 
calculated on the raw data to test the significance of any differences in 
the mean symptom scores and for comparrison with previous studies, 
while scatter diagrams will be drawn to search for any linear 
relationship between the members of the study triads. 
2.12 ANALYSES OF THE DATA 
In order to calculate the kappa using SPSS, for personal computer, each 
cell of the chi square cross-tables must be filled. Using the 1 DO mm 
scale many of the 200 cells remained unfilled. Furthermore, using the 
10 em scale, some of the sub-scales had empty cells in the cross-tables 
prohibiting calculation of the kappa statistic. 
To facilitate the calculation of kappa the VAS raw scores will be 
converted from a 100 point scale of 1 mm each to a ten point scale of 
1 em each by rounding up or down from the 0.5 em mid point 
between the 1 em gradations. For example 0 to 4.9 mm - 0 em, 5.0 
to 14.9 mm- 1 em, 95.0 to 100 mm- 10 em. The VAS raw scores 
will be further converted to a three point scale; "Mild/Absent" (0 to 29 
mm). "Moderate" (30 to 59 mm), and "Severe" (60 to 100 mm); as well 
as a binomial one; "Absent" (VAS 39 mm or less) and "Present" (VAS 
40 mm or greater). Such conversions, performed in some of the 
studies listed in Table XIV, make clinical sense in that if the 
assessments of the family and nurses are greatly divergent from those 
of the patient, scales of a coarser nature will detect this divergence 
while finer, and perhaps clinically non-significant, divergences will be 
lost. Finally, with conversion to the coarser scales the statistical 
treatment wi II be feasible. 
The means and standard deviations of the unconverted raw data will 
be calculated in the usual ways using SPSS for personal computer. The 
Student's t-test for paired data will be calculated, on the unconverted 
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raw data, to assess the significance of any differences in mean 
symptom ratings between patient and family member and between 
patient and nurse. 
2.13 SUMMARY 
The aim of this observational study is to assess the level of agreement 
on the perceptions of cancer related symptoms as rated by the patient 
and a close family member and by the patient and the nurse. The 
Edmonton Symptom Assessment System !ESAS) will be the instrument 
used to rate nine symptoms commonly encountered in the cancer 
experience. 
All cancer patients admined to each of three hospital wards will be 
eligible for recruitment into this study. Those well enough to 
participate will be invited by the charge nurse of the ward to meet the 
investigator who will subsequently invite the patient and family 
member to complete the ESAS. The patient's nurse will also complete 
the ESAS at about the same time. 
Because of technical issues involving SPSS for personal computer, for 
ease of analysis, and following precedent displayed in the literature, 
the VAS scores of the ESAS wi II be converted from a 100 mm scale in 
three ways to 1) a ten point scale, 21 a three point scale, and 3) a 
binomial scale. 
The raw data wi II be treated as ordinal data for the parametric tests and 
Spearman's rho, while the converted data will be subjected to the non 
parametric tests of agreement. The means and standard deviations will 
be calculated for the 100 mm scale data in the usual way and the t-test 
calculated to assess the significance of any differences in symptom 
assessment between the subjeds. The Kappa statistic will be calculated 
using SPSS for the three converted scales. Although percent agreement 
is a simplistic measure of agreement this statistic will be calculated to 
allow comparison with what other studies have reported. 
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CHAPTER Ill 
LITERATURE REVIEW ON THE USE OF VISUAL ANALOGUE SCALES 
TO MEASURE SYMPTOMS COMMONLY SUFFERED BY PATIENTS 
WITH CANCER AS RECORDED BY THE ESAS 
3.1 INTRODUCTION 
This chapter begins with a discussion of the development and research 
uses of the visual analogue scale prior to a more lengthy discussion of 
the validation of this scale as a measurement tool for the subjective 
phenomena of cancer-related symptoms. 
Using the Silver Platter program a Medline search of the literature was 
performed using MESH headings of Visual Analogue Scale and each of 
the following nine symptoms that are commonly associated with 
cancer as measured by the Edmonton Symptom Assessment System 
(ESAS): pain, nausea, tiredness, depression, anxiety, shortness of 
breath, drowsiness and appetite. Dyspnoea was substituted for 
Shortness of Breath as the former term is a MESH heading while the 
latter term is part of the ESAS. The search combining drowsiness and 
visual analogue scales turned up no references; however the search 
combining insomnia and visual analogue scales did find references, but 
because drowsiness and insomnia differ substantially those articles 
were not reviewed. 
Most of the articles, found during the initial search process, on 
symptoms other than pain, actually used the VAS to measure pain 
while referring to the other symptoms in passing. 
The abstracts of the citations in English were scanned and only those 
studies that attempted to demonstrate validation of the VAS by 
comparing it with other measures were reviewed in depth. 
Table Ill shows the results of this literature search. 
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TABLE Ill: RESULTS OF A LITERATURE SEARCH 
CONCERNING THE USE OF THE VISUAL 
ANALOGUE SCALES IN ASSESSING THE 
COMPONENTS OF THE EDMONTON 
SYMPTOM ASSESSMENT SYSTEM 
Symptom Total Citations English 
Citations 
Pain 1,0S1 934 
Shortness of Breath 27 22 
Nausea 129 111 
Depression 135 113 
Anxiety 121 101 
Tiredness 10 8 
Drowsiness 24 20 
Appetite 17 15 
Well Being 0 0 
TOTALS 1,514 1,324 
3.2 VISUAL ANALOGUE SCALES (VAS) 
Reviewed 
Articles 
15 
8 
7 
7 
10 
3 
1 
2 
0 
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The VAS was first introduced and described in the medical literature 
in the early 1920's by Dr. M Freyd". They were re-introduced for the 
measurement of feelings in 1969 by Dr. R.C.8. Aitken of Edinburgh, 
Scotland, who commented that the VAS was superior to adjectival 
descriptors of feelings and stated, "Words may fail to describe the 
exadness of the subjective experience." Aitken27• 
The VAS has differing lengths and forms, linear or bipolar (see section 
on Shortness of Breath) and may be vertical or horizontal. The most 
common and the form used in the ESAS is horizontal and 100 mm in 
length. The scale is anchored at each end with the two extremes of the 
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symptom in question, for example when considering pain the anchors 
are "No Pain" and "Worst possible Pain". 
To rate each symptom the subject makes a mark with a pen or pencil 
at a place along the line, between the two extremes, appropriate to the 
quantity of feeling at the time. 
In 1969 Aitken reviewed some of the experiments he had conducted 
using the VAS. He compared aircraft pilots' descriptions of safety issues 
with their relative importance and had independent judges assess the 
same relative importance using a series of VAS ratings. He calculated 
significant reliability of concordance by Kendall's coefficient for each 
safety issue. Spearman's rank correlation coefficient was used to assess 
concordance between scores and areas of relative importance. 
Although the actual statistical results were not offered in this paper, 
Aitkin produced the histograms of the raw VAS scores from three of his 
studies to show the normal distribution, after arcsine transformation, 
and thereby to conclude that the scores "fulfilled the necessary 
requirements for analysis of variance: homogenous and independent 
variance, normal distribution (with arcsine transformation) and 
sufficient resolution in measurement to provide continuous rather than 
discrete scores." Aitken17 . 
The debate on the analysis of VAS scores continued when in 1974 two 
British scientists, Bond and Lader", administered sixteen 1 00 mm 
VAS measures concerning feelings to 500 healthy volunteers whose 
ages ranged from 16 to 64 years. This heterogenous sample was made 
up of employees of technical colleges, universities, and hospitals. The 
authors presented a frequency histogram of all scores between 45 mm 
and 55 mm to disprove the hypothesis that subjects tended to cluster 
their scores about the middle. They concluded that test-retest 
assessments of internal validity would be inappropriate as the scales do 
not rate stable phenomena but measure feelings in the here and now. 
The distributions of the sixteen sub-scale scores were not normal in 
every case: those titled Clear Headed, Tranquil, Proficient, Relaxed, 
and Amicable were skewed to the positive; Calm, Well-coordinated, 
Contented, Happy and Interested were negatively skewed; while Alert, 
Strong, Energetic, Quick-witted, Attentive, and Proficient were normally 
distributed. The authors found conversion of the raw scores into 
natural log scores aided their factor analysis which revealed three 
factors (Alert, Happy, and Calm) accounted for 61% of the total 
variance. They could not account for the skewedness of the rating 
scores in their healthy population, however such distributions might 
occur in a study of ailing subjects because of their illness. The authors 
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noted the scales were quick to fill out, easy for the subjects to 
understand, did not require much subject motivation, and the rater is 
not restricted by adjectives or direct quantitative rankings. 
By 1978 the VAS was becoming more common in medical research 
that measured subject self-rating of feelings. Maxwell" studied the 
ability of the 100 mm VAS to measure seven volumes of sound offered 
to 27 healthy volunteers and repeated the testing one day later. The 
VAS was found to be simple to explain and use and largely acceptable 
to the subjects. Arcsine conversion of the raw scores did not aid 
analysis while sensitivity was improved through conversion to 
proportional scores (1 00 x raw score/maximum score) which was done 
because some of the subjects rated their maximum score as less than 
35. The product moment correlations of the mean scores and the 
volume settings were statistically significant r - 0.96 (p < 0.001) on 
both days. Although commenting that the sensitivity was adequate if 
not completely satisfactory this author found 5 of the 49 (1 0%) 
statistically significant results to be wrong in that a higher volume of 
sound was rated by the subjects on the second day as being lower. 
Maxwell concluded that concerning statistical analysis of significance, 
"it makes little difference most of the time whether parametric or 
ordinal tests are used", and that large differences (greater than 10 mm) 
can be tested for significance by parametric tests. W ithin-subject 
comparisons were more accurate than those between subjects. 
Although the VAS has value, it is not a perfect tool, a situation alluded 
to above but amplified by Downie et al in 197810• These authors 
tested the grip strength of 7 healthy volunteers and 93 out-patients 
suffering from arthritis in three ways: 1) clinical assessment by a 
physician (three finger squeeze), 2) objective assessment with a 
sphygmodynamometer, and 3) a 100 mm VAS rating by the subject of 
their subjective strength. Based on objective assessment the subjects 
were divided into four groups: very weak, weak, normal, and strong. 
Using a correlation matrix the authors found reasonable correlation 
between VAS and objective assessment (r- 0.6358, p < 0.001) and, 
offered here as contrast, between Physician and objective measure (r 
- 0.9177, p < 0.001). However further analysis revealed that the 
correlations were not as strong between the four sub groups and the 
VAS. For those subjects who were: Very Weak r - 0.5651 (p - NS). 
Weak r - 0.0219 (p - NS). Normal r - 0.4918 (p < 0.001), and 
Strong r - 0.4107 ( p - NS). The authors suggest caution when using 
the VAS to measure subjective experience. 
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3.2.1 SUMMARY 
Based on these studies, the VAS as a tool to measure subjective 
experience appears to result in scores of an ordinal nature. By selecting 
an arbitrary cut off (scores between 20 mm and 40 mm have been 
used) the scale can be employed as a binomial one with those scores 
above the cut off indicating the presence of the symptom; with those 
below, its absence. The median could also be used as the binomial cut 
off. 
Further division of the scale into ten gradations (of 10 mm each) or 
into three (absent: 0- 29 mm, mild: 30 - 59 mm, or severe: over 60 
mm) will result in scores of an ordinal nature. 
The VAS has been shown to measure subjective phenomena such as 
symptoms; is easily understood, can be taught quickly, requires little 
subjed motivation, and results in scores of an ordinal nature whether 
used as a 100 mm, 10 em, or a three point scale. 
3.3 PAIN 
The measurement of pain using the visual analogue scale (VAS) has become 
quite popular of late among pain researchers who report their findings 
in those medical publications listed in Medline. The VAS has been 
compared with other more complex and time consuming pain 
measures and has been found to be reliable and sensitive to change. 
3.3.1 CANCER-RELATED PAIN 
In 1975 Ohnhaus and Adler" made multiple comparisons, in six 
cancer patients, of the effects on pain of two different analgesics and 
a placebo. Pain was measured by a 100 mm VAS and a verbal rating 
scale. The authors reported a good correlation between scales (r -
0.81, p < 0.00 1); and concluded that, compared with the verbal scale, 
the VAS scale assessed more closely changes in the pain experience of 
their subjects. 
Graham et al·32 studied 36 out-patients suffering cancer related pain 
which was assessed by the McGill Pain Questionnaire, an extensive 
and well validated self-rating tool to measure the cancer pain 
experience. Sixteen subjects also had their pain assessed using a 100 
mm scale. Based on the 100 mm scale pain scores, these 16 subjects 
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were subsequently divided into high or low pain sub-groups. The mean 
pain scores of these two groups were compared using a t-test. The 1 00 
mm scale and the Present Pain Intensity Index, part of the McGill 
Questionnaire, could distinguish between the two sub-groups (p < 
0.01, 2 tailed). The authors concluded that the VAS could distinguish 
between patients with high or low pain intensities. 
Wallenstein, et al 11 studied 34 cancer in-patients using a VAS and a 
set of 8 categorical pain descriptors modified from the Tursky Pain 
Perception Profile", a commonly used pain scale from the late 
1970's. The measurements were done repeatedly over time (total of 
1,300 measurements) in both oncology patients and those recovering 
from cancer related surgery. The authors found the relationship 
between the two scales to be a power function and that the VAS scale 
correlated well with the categorical scale lr' - 0.65). The VAS seemed 
to be more sensitive to smaller changes in pain than did the categorical 
scale. 
Kremer et a\ 15 used three scales: VAS, numerical, and adjedival 
scales; to assess the pain of 56 patients suffering cancer related pain. 
Although reported but not methodologically described, the 
intercorrelation of the pain intensity ratings were: VAS and numerical 
scale, r - 0.86 (p < 0.05) and VAS and adjectival scaler - 0.64 lp 
< 0.05). An Anova of the three scales showed no difference in pain 
ratings. By the 1980's pain measurement had begun to evolve towards 
using simpler and shorter scales. One such scale is the Memorial Pain 
Assessment Card, an 8 item descriptor scale and 3 VAS measures (pain 
intensity, mood, and pain relieO. Fishman et al" reported on the one 
time assessment of SO cancer in-patients comparing the various 
components of this card with the McGill Pain Questionnaire and the 
Tursky assessment tool. The Spearman correlations were: VAS (pain 
intensity) and the Tursky, rho - 0.67 (p < 0.001) and VAS (pain 
intensity) and the McGill, rho - 0.45 (p < 0.001). 
3.3.2 NON CANCER-RELATED PAIN 
Thirty subjects suffering chronic musculoskeletal pain and 20 healthy 
volunteers were studied by Price, et aP7 who exposed their subjects 
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to six gradations of painful noxious thermal stimuli applied to the 
forearm. The relationship between skin temperature and the sensation 
intensity as measured by the VAS was curvilinear while the 
relationship between log skin temperature and log VAS intensity was 
linear. The authors concluded the VAS to be a valid instrument to 
measure, within subjects, changes in pain intensity. 
Linman et al" reviewed 23 studies that compared the VAS and a 
verbal pain intensity scale in clinical trials of analgesic use with 14 
protocols and 1,497 subjects suffering a variety of pain syndromes. 
Pearson product moment correlation coefficients were determined for 
the sum of VAS rated differences of pain (pre and post analgesic) and 
the equivalent sum rated by the verbal pain intensity scale. The 
correlation for 1330 subjects in whom all data could be found was so 
high (r -0.9331 that the authors conclude there was no difference in 
sensitivity between the VAS and the verbal descriptor scale. 
Revill, et al" in 1976 studied the pain recall of twenty women who 
had recently experienced childbirth. The investigators first studied the 
visual motor skills needed to complete the VAS finding no difference 
in ability to complete the VAS whether or not the subjects had been 
given the sedating analgesic, pethidine. These authors reported stable 
scores of memory recall after five minutes and 24 hours (r- 0.967, p 
'very highly significant'). They also studied four lengths of scale: 5, 
10, 15, and 20 em; finding significantly greater variability in the 5 em 
scale. They concluded that scales of 10, 15, and 20 em rating a 
constant pain stimulus are reproducible, and for different pain stimuli. 
measure real change in their subjects' pain perception . 
Downie et al."0 reported on 100 rheumatic patients who rated their 
pain with three commonly used scales: Ill the VAS, 121 an eleven 
block vertical column rating pain from 0 to 10, and 131 a simple 
descriptive scale (nil, mild, moderate, severe, and very severe). The 
subjects were tested once with each scale after a 'washout' period. 
Correlation coefficients were: VAS and numerical scale, r - 0.64; VAS 
and descriptive scale, r - 0.705. Although no measures of significance 
were supplied the correlation coefficients were acceptable indicating 
that the VAS measures pain almost as well as the other two methods. 
While studying episiotomy pain in 26 women, Reading" compared 
the VAS with other commonly used pain scales: a verbal scale (mild, 
discomforting, distressing, horrible, and excruciating), a 10 point 
numerical scale, and a variant of the verbal descriptive component of 
the McGill Pain Questionnaire. Using Pearson Product Moment 
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correlations the authors found the verbal scale and the numerical scale 
did not correlate with each other (r - 0.26), neither did the verbal 
scale correlate with the VAS (r - 0.29). The numerical scale and the 
VAS correlated somewhat (r - 0.46, p < 0.01). 
Linton and Gotestam" studied 15 patients with chronic pain 
comparing, over repeated measurements, the pain intensity rated by 
the VAS and a verbal descriptive scale. Five patients rated their pain 
exactly the same each day and were thus excluded from the Pearson 
product moment correlation analysis which showed a correlation for 
the remaining ten subjects of 0.68 (p < 0.05). It would appear that 
five subjects either didn't have day to day pain fluctuations (as did 
the other ten) or were unable to rate pain using either scale. 
jensen et al" studied the pain reported and rated by 75 patients 
with chronic pain using six methods: (1) the VAS, (2) a 101 point 
numerical scale, (3) an eleven item box scale, (4) a 6 point 
categorical descriptive behaviour scale, (5) a five item verbal 
categorical scale, and (6) a four item verbal categorical scale. The 
latter five scales measuring current pain correlated well with the 
VAS: r -0.71 (p < 0.001, 2 tailed). 
Hurst et ar"4 compared in 233 rheumatoid arthritis patients the 
use of the VAS with the Stanford Health Assessment Questionnaire 
and a newly developed scale. For moderate or severe pain as 
measured by the Stanford scale the mean VAS scores were 
associated (p <0.001) using at test. Such an association was not 
noted at the mild discomfort level. These authors, among others, 
used the VAS for pain as a part of the gold standard to validate their 
new scale. 
By the 1990's the assessment of pain in research protocols had 
begun to include a VAS scale even when other pain assessment 
measures were used. Beattie et a1" employed a double blind 
randomized controlled trial design to study the effects of ketorolac 
use in 69 (vs 61 placebo controls) post operative subjects measuring 
the pain with a VAS as well as recording pulse and BP. All three 
measures were higher (p <0.001 to 0.05) in the control subjects 
compared with those receiving the drug. This is indirect evidence of 
the relationship of VAS scores to the pain experience. 
3.3.3 SUMMARY 
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The VAS used either once or repeatedly to measure the pain 
experience appears to be a tool that is valid, reproducible, and 
sensitive to change. The scale is easy to use, quick and clinically 
appropriate as well as being acceptable for use in the research of 
pain. 
3.4 SHORTNESS OF BREATH 
The use of the VAS to assess Shortness Of Breath (SOB) has a much 
shorter history than does that for pain assessment. Two versions of 
the VAS are described in the literature; a 100 mm vertical or 
horizontal line anchored allhe ends by the phrases "no shortness of 
breath" and "shortness of breath as bad as il can be", and a bipolar 
type comprised of a 200 to 400 mm line anchored at the ends by 
the phrases "very much worse" and "very much better" with "no 
change" in the middle of the line. I could find no studies comparing 
the two types of scales. 
3.4.1 CANCER-RELATED SHORTNESS OF BREATH 
Booth and colleagues" studied the use of oxygen or compressed 
air delivered in a randomized, blinded fashion via nasal prongs at 4 
1/min in 38 subjects with advanced cancer in the lungs. Shortness 
of breath was measured by the Borg scale (a 10 category scale to 
measure dyspnoea), a 1 00 mm horizontal VAS, and a qualitative 
assessment by the subject. A pulse oximeter was used to assess 
arterial oxygenation. The authors reported the pattern of responses 
to be the same for the Borg scale and the VAS but did not supply 
statistical testing results to support this conclusion. Dyspnoea, as 
measured by the VAS, was significantly reduced (p < 0.001) by 
breathing compressed air or oxygen when compared with breathing 
room air. These authors appear to have used the VAS as a 
measurement standard. 
3.4.2 NON CANCER-RELATED SHORTNESS OF BREATH 
Gift" studied 16 asthmatic and 30 COPD recently admitted in-
patients using both the vertical and horizontal VAS and a lest of 
peak expiratory flow rate to compare the dyspnea perceived by her 
subjects with an objective measure of dyspnea. The ratings were 
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done on admission and those subjects who demonstrated less than 
1 SO lpm of peak flow were assessed again prior to discharge. The 
construd validity (does the VAS measure shortness of breath?) was 
assessed by using t tests between the subjects' mean VAS scores 
during the times when peak flow was higher (not dyspnoeic) or 
lower (dyspnoeic). Concurrent validity (do the tests of dyspnoea 
concur?) was tested between the two VAS ratings and the peak flow 
measurements using Pearson product moment correlation's. The 
correlation between vertical and horizontal scales was - 0.95, 
between vertical scale and peak flow - 0.85 and between horizontal 
scale and peak flow - 0.71. No tests of significance were offered. 
Statistically significant differences were recorded in the VAS rated 
shortness of breath between times of lower and higher peak flow: t 
- 12.35 for asthmatics (p <0.01) and t- 9.73 for COPD subjects 
(p <0.01). The vertical VAS was simple to use and valid for 
measuring and monitoring patients' perceptions of dyspnoea. The 
horizontal scale was almost as good a measure as the vertical scale. 
Noseda et al" studied perceptions of SOB in 12 asthmatic and 12 
COPD subjects using the VAS after inhalation of the 
bronchoconstriding agent histamine. The VAS was of the bipolar 
variety. The subjects' pulmonary functions were also assessed using: 
forced expiratory volume in one second, specific inspiratory airway 
resistance, functional residual capacity, and inspired vital capacity. 
Five of the 12 COPD subjeds demonstrated little or no induced 
change in respiratory function and were classified as "low 
perceivers". These subjects were found to have poor correlations 
between VAS ratings and objedive measures of lung function. The 
authors used the Pearson correlation coefficient and a stepwise 
multiple regression analysis to test relationships between the VAS 
and the five physical measures. They found that the VAS 
demonstrated a statistically significant relationship with specific 
airway resistance (r - .953, p - .0221 and FEV1 (r - .934, p -
.002) in asthmatics and with inspiratory vital capacity (r - .81 , p -
.0 1) and maximal inspiratory flow at 50% forced vital capacity (r -
.805, p - .003) in COPD subjeds. Although histamine induces 
bronchoconstriction it does so inconsistently and these authors 
could not prove a dose response association. However the 
association between the VAS-assessed SOB and objedive measures 
of lung fundion demonstrates the usefulness of the VAS type of 
measure: in asthmatics the measure is more consistant than those 
with COPD as the former subjeds appeared more homogeneous in 
their response to shortness of breath. 
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The same group of investigators"9 studied perceived VAS-measured 
SOB in 16 asthmatic and 16 COPD out-patient clinic attenders who 
received inhalations of saline followed by terbutaline. The VAS used 
was again the bipolar 400 mm variety described above. The 
investigators measured lung functioning six times, at baseline and 
once after each of three saline and two terbutaline inhalations. The 
tests were: specific inspiratory resistance, specific expiratory 
resistance, functional residual capacity, FEVl, inspired vital capacity, 
total lung capacity, and the VAS. Eight of the sixteen COPD 
subjects were classified as "low perceivers" and compared to 
baseline assessments showed little variation of either lung function 
or VAS ratings following the inhalations. The investigators used the 
Spearman correlation coefficient and the Wilcoxon signed rank test 
to evaluate the significance of concordance between the post-
terbutaline and the post-saline inhalations. All rankings listed were 
statistically significant (p < 0.05 with most p < 0.01). In the 
asthmatics and COPD "high perceivers" the specific inspired 
resistance, specific expiratory resistance, and inspired vital capacity 
all correlated well with the VAS. Only the asthmatics showed a 
statistically significant correlation between VAS ratings and 
functional residual capacity, FEV1 demonstrated a weak, non 
significant relationship with VAS ratings. 
The same group" compared terbutaline-induced bronchodilation 
as measured by the lung function studies described above with 
decreasing shortness of breath as rated by the bipolar VAS. Their 
subjects were 36 out-patients, 16 with asthma, 20 with COPD; 2 
asthmatic and 7 COPD subjects were "low perceivers".The 
investigators tested the relationships using the squared correlation 
coefficient within a linear regression analysis. They found 
statistically significant relationships between VAS ratings and specific 
inspiratory resistance in the asthmatic (r' - .831 , p < 0.01) and 
"high perceiver" COPD subjects (r' - .760, p < 0.05). Given the 
large numbers of lung function tests done and the only slightly 
smaller number of negative results, one might expect that some 
positive results might occur by chance alone. 
Noseda and colleagues" used the bipolar VAS to measure 
dyspnoea in 19 COPD patients as they exercised in a lab against 
both progressive and high intensity resistance. Ventilation, as 
measured by V02Max, VEMax, and heart rate, correlated well with 
dyspnoea (r > 0.90) in 15 subjects and well enough in the 
remaining 4 subjects (r - 0.747, 0.840, 0.865, and 0.888). 
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Wilson and Jones" also compared the Borg Scale and the VAS to 
measure dyspnoea while testing the minute ventilation in 10 
healthy subjects who were exercised in a lab. The authors found 
statistically significant relationships (p < 0.01) between the minute 
ventilation and the VAS score (r - 0.68) and the Borg score (r -
0.75) using analyses of variance and covariance. The VAS scores 
displayed a wider range than the Borg and the coefficient of 
determination for the two scales was 0.71 (no tests of significance 
reported). These authors concluded that both scales measure 
dyspnoea but suggest the Borg scale seems somewhat better as a test 
of dyspnoea in healthy subjects. 
Gift et al 53 made multiple measurements of VAS-rated SOB, serum 
cortisol, p02, pCo2, anxiety, use of accessory muscles, depression, 
and somatization in 6 male COPD subjects of mean age 64 years. 
The investigators divided their subjects into high or low dyspnoea 
perceivers based on their VAS ratings and compared the remaining 
measurements between these two groups. The t test was used to 
compare the means of each measurement between low and high 
dyspnea levels. The differences between the two sub-groups of 
subjects were statistically significant for measurements of anxiety (t 
- 2.8, p - .01 ), cortisol concentration (t - 2.6, p - 0.02), 
depression (t - 2.1, p - .04), PC02 (t -2.1, p - .04), and use of 
accessory muscles (t - 5, p - .002); while somatization and p02 
were not different. These results indicate a physiologic difference 
within subjects when short of breath compared to when they were 
not, and that the VAS can be used to measure these differences. 
3.4.3 SUMMARY 
Although not as fully studied nor as well validated as the VAS for 
pain, the VAS for shortness of breath appears to be valid and 
sensitive to change in healthy, asthmatic, and high perceiver COPD 
subjects. The one study comparing the VAS to other objective 
measures of dyspnoea in cancer subjects indicates this measure is 
useful in this group. 
3.5 NAUSEA 
Nausea is a subjective experience as well as an observable 
physiologic phenomenon, with sweating, pallor, and sighing; and 
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has been difficult to reliably quantify. Morrow" reviewec 144 
articles on the assessment of nausea noting a vast variety of self and 
observer rating scales including: binomial { "present I absent" or 
"yes I no" assessments), 3 -point, 4 - point, 5 - point, 6 - point, 10 -
point scales and the 1 00 mm VAS. Because he felt none of these 
scales to be sufficient he developed his own which he used to test 
20 chemotherapy subjects before and after each of four 
chemotherapy sessions. He offers acceptable mean test-retest 
reliability coefficients but did not compare his scale with the 100 
mm VAS. He concluded, although he did not offer much statistical 
testing to strengthen his argument, that self-rating of nausea was 
quite appropriate. 
3.5.1 CANCER-RELATED NAUSEA 
By 1990 the competition between the commonly used nausea rating 
scales had thinnec to the VAS, a VAS variant, and discrete 
descriptor scales. Del Favero et al 55 were involved in four double-
blind randomized clinical trials and two observational trials of 
chemotherapeutic agents and nausea. They compared the self-ratings 
of nausea offered by 849 subjects using three scales: a 1 00 mm 
VAS anchored by "no nausea" and "worst nausea I've ever felt", a 
100 mm analogue chromatic continuous scale {descriptively 
anchored the same as the VAS but gradec in colour from pale pink 
to dark red) and a discrete descriptive scale (none, mild, moderate, 
severe). The authors reportec that 95% of subjects were able to 
complete the rating scales. Spearman's correlation coefficients were 
computed for maximum intensity, presence, and quantity of nausea. 
Correlation of the discrete scale vs VAS revealed the following: for 
intensity r - 0.68, for presence r - 0.80, and for quantity r - 0.95 
(all p < 0.05); while correlations between the VAS and the 
chromatic scale were: for intensity r - 0.74, for presence r - 0.87 
(both p < .001 ), while for quantity the correlation was poor. There 
appears to be no advantage of one of these three scales over the 
others. 
Bruera et al" studiec the use of controllec and immediate release 
metoclopramide in twenty-nine patients with advanced cancer and 
severe nausea. They usee the 1 00 mm VAS anchored as above and 
a three point descriptive scale ( mild, moderate, and severe) with 
appropriate amplifiers further describing the categories. They also 
recorded episodes of vomiting and patient preference between the 
short or long acting anti-vomiting agent. The patients who had 
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higher vomiting scores also had higher VAS scores and higher 
categorical scores but no direct comparisons between the latter two 
measures were reported . 
In Sweden, Borjeson and partners57 studied the nausea suffered by 
104 women with cancer over four chemotherapy sessions. Both the 
100 mm VAS and a four category scale (none, mild, moderate, and 
severe) were used to assess nausea resulting in 348 simultaneous 
ratings. The authors reported the mean VAS scores for those subjects 
who rated their nausea on the categorical scale as follows none -
0.7 mm, mild - 24.8, moderate - 48.3, and severe - 75 .1. 
Neither tests of correlation nor association were reported. 
3.5.2 NON CANCER-RELATED NAUSEA 
In an experimental design, Muth et al 58 invited 50 healthy 
subjects to sit in an optokinetic rotating drum for si xteen minutes of 
nausea-inducing gyrations. Using a newly designed descriptor scale 
(modified from Morrow as described above) and a 300 mm VAS 
anchored similarly as above, they recorded the self rated nausea of 
their subjects. Their scale correlated well with the VAS (r - .71 , p 
< 0.01) while both scales could distinguish those susceptible and 
those not susceptible to motion sickness It - -6.77, p < .001). They 
concluded their scale had an acceptable construct validity because 
of its high correlation with their VAS. They did not test their 
subjects with the 100 mm VAS. 
The following two studies are reported here as examples of how the 
VAS is being currently used to measure nausea in clinical trials. 
Miguel et al" studied the effects of sufentanil given either 
intravenously or via the epidural route on narcotic requirements of 
50 subjects in the post operative phase of abdominal surgery. The 
investigators used the 1 00 mm VAS for nausea finding no 
differences between the two groups. The average nausea score for 
the epidural group was 10 mm: for the intravenous group, 3 mm. 
Sohi and associates60 used the 100 mm VAS to assess post 
operative nausea of 125 patients undergoing cholecystectomy in a 
double blind controlled trial on the use of preoperative 
scopolamine. They found no difference between the drug and 
control group. The highest mean level of nausea was 25 mm. 
3.5.3 SUMMARY 
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By the mid 1990's the 1 00 mm VAS was being used as the most 
common measurement of nausea in studies of anti-emetic agents and 
of those causing nausea such as cancer chemotherapeutic agents. 
Despite the lack of correlation and agreement analysis I conclude 
the VAS appears to be as valid a tool to measure patient 
experienced nausea as any other that exists. 
3.6 DEPRESSION 
3.6.1 CANCER-RELATED DEPRESSION 
Ahles et at" studied 29 out-patients and 11 in-patients who were 
suffering from cancer related pain. They administered the VAS daily 
and once for each of the Beck Depression Inventory (a 21 item self 
report questionnaire) and the Symptom Checklist ·90, two 
commonly used screening tools for depression of mood. The 
correlation coefficients (not further defined) for VAS vs the Beck 
Depression Inventory was 0.51 (p < .OS) and for VAS vs the 
Symptom Checklist r - 0.41 (p < 0.05). The authors suggest their 
data support the validity of the VAS as a practical instrument for the 
measurement of mood in patients suffering cancer related pain, 
however the correlation coefficients were not really high enough to 
support this conclusion with any degree of certainty. 
Chochinov and cohorts62 interviewed 197 in-patients suffering 
from advanced cancer. They conducted a structured clinical 
interview to determine the presence or absence of depression and 
then tested each subject for depression using three methods: the 100 
mm VAS, the Beck Depression Inventory-short form, a one item 
interview (Are you depressed?), and a two item interview (one 
question each about depressed mood and loss of interest). A total of 
24 subjects met the interview criterion for depression. The 
investigators compared the structured interview with the other four 
measures. The sensitivity and specificity were found to be: single 
item interview 1.00 and 1.00, two item interview 1.00 and 0.98, 
Beck 0.79 and 0.71, and VAS ( < 55 mm) 0.72 and 0.50. These 
results demonstrate that either: the VAS is inferior to the other tools 
as a measure of mood in patients with advanced cancer, or that 
depression is not well defined by the VAS score cutoff of 55 mm. 
Although the authors did not discuss the range of the VAS mood 
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scores, a cut-<Jff of 55 mm seems quite high. People with advanced 
disease may rate their mood as low because of the sheer immensity 
of their illness but not consider themselves clinically depressed. 
3.6.2 NON CANCER-RELATED DEPRESSION 
Luria6 3 studied 62 recent in-patients with fundional psychiatric 
disorders. The subjects were grouped by diagnostic categories and 
mood was tested with repeated 1 00 mm VAS measurements, a one 
time assessment using the Self-rating Depression Scale (multiple 
choice descriptive scale) and the Clyde Mood Scale (multiple choice 
scale), a structured clinical interview, and clinical impression of 
mood while on the ward. Correlation was tested using the Pearson 
correlation coefficient between the VAS and the Self-rating 
Depression Scale: r - -0.56 lp < 0.001) and between the VAS and 
the "Unhappy" sub scale of the Clyde Mood Scale: r - -.65 (p < 0 
.001). Clinical impression of mood correlated well with VAS scores 
in non schizophrenic subjects (mean r ranged from 0.61 to 0.56 , 
p< .001). Reliability using a within-patient test-retest methodology 
showed a mean r of 0.59 for those subjects with affective psychoses 
while for schizophrenic subjects mean r - 0.56 and for personality 
disordered subjects mean r -0.74 (all p <.001). Across-patient test-
retest reliability coefficients at 2 hours ranged from 0.73 to 0.91 IP 
< 01 ). The author concluded the VAS was valid and correlated well 
with the other two often used scales of mood assessment. 
Folstein and Luria"' studied 133 military personnel recently 
admitted because of psychiatric or orthopaedic illness and 33 
patients hospitalized because of psychiatric illness. Their subjects 
were tested for mood by a) a 100 mm VAS titled "How is your 
mood right now?" anchored by "Your worst mood" and "Your best 
mood", b) the Self Rating Depression Scale, and c) the Clyde Mood 
Scale. The VAS was completed daily while the latter two scales 
were administered once each. The VAS scores were compared with 
each subject's scores on the other two scales. The correlation 
coefficients for the military personnel group were VAS vs Self Rating 
Depression Scaler - -0.64 (p < 0.001) and VAS vs Clyde 
Unhappy Scale r - -0.38 (p < .01) and for the hospitalized 
psychiatric subjects: VAS vs Self Rating Depression Scaler - -.67 (p 
< .001 ) and VAS vs Clyde Unhappy Scaler- -0.51 (p < 0 .001). 
The VAS appeared to measure true differences in mood between 
subjects whether they were admitted with psychiatric or orthopaedic 
diagnoses. The VAS correlated well enough with the other two 
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scales to indicate its validity as a true refledion of how a subjed 
perceives mood. The subjeds in this study were, overall, quite 
young: mean age of the military group was 22 years, and no gender 
controls were avai I able. 
Rosenberg et al/'5 recruited 472 out-patients who were depressed 
enough as to require antidepressants. The investigators assessed the 
mood of their subjects using the 100 mm VAS, the Hamilton 
Depression Scale, a commonly used test of mood that is 
administered by a trained operator, and the Clinical Global 
Impression Scale. Although no formal correlation testing was 
performed the authors noted their subjects' VAS ratings showed 
similar improvements to those of the other two scales. This gives 
only indired evidence that the VAS measures mood as well as the 
other two scales. 
While studying the effeds of danazol on the symptoms of 
premenstrual tension in 28 women Hahn66 and colleagues used 
the VAS and Beck Depression Inventory to assess mood. The authors 
found statistically nonsignificant differences in mood between 
placebo and drug group using these scales. No comparisons were 
made concerning the Beck scale and the VAS. The author's use of 
the VAS as a complement to the Beck scale indicates their 
confidence of the VAS but little else. Bloch et al" used the VAS, 
the Clinical Global impression Scale, and the Hamilton Rating Scale 
for Depression to assess the mood of 33 depressed out-patients 
undergoing a trial of antidepressant plus either placebo or lithium. 
All three scales measured statistically significant (p < .001) 
improvement in mood as the treatment progressed. No formal 
testing of correlations between tests was made. These authors' 
findings give indired evidence that the VAS is as good as the other 
two scales and indicate the VAS does measure change in mood as 
depression lifts. 
To study the effeds of antidepressant medication combined with 
sleep deprivation in 51 depressed patients, Kuhs et al" measured 
each subjed's mood using the VAS and the Hamilton Rating Scale 
for Depression. The mood scores improved after treatment as 
measured by the Hamilton scale but not by the VAS. Although no 
formal correlations were made between the two scales this study 
casts doubt on the suitability of the VAS to measure changes in 
mood. 
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3.6.3 SUMMARY 
Overall the body of evidence supports the view that the VAS for 
depression is able to distinguish between subjects with low or high 
mood and to measure improvement in the mood of depressed 
individuals as they respond to anti-<iepressant therapy. 
3.7 ANXIETY 
3.7.1 CANCER-RELATED ANXIETY 
Miller et al" studied the pre-operative anxiety of 44 women about 
to undergo surgery for breast cancer using the Hospital Anxiety and 
Depression Scale, the Spielberger State Trait Anxiety Inventory and 
the 100 mm VAS anchored by "Not anxious at all" and "Most 
anxious I can imagine." The Pearson product moment correlations 
for the anxiety component of the scales were: VAS vs Hospital Scale 
0.74, VAS vs Spielberger Inventory 0.62 and between the Hospital 
Scale and Spielberger Inventory 0.81 (all p <.001). The mean VAS 
score for anxiety was 50.3 with a standard deviation of 28.35. This 
study shows the VAS is acceptable and nearly as good at measuring 
anxiety as the other two commonly used scales. 
3.7.2 NON CANCER-RELATED ANXIETY 
In 1975 Bond and Lader" used a series of 16 (100 mm) VAS 
ratings to measure the calming effects of either placebo, 
butobarbitone, flurazepam 15 mg, or flurazepam 30 mg on the 
subjective feelings of 500 healthy volunteers. The authors performed 
a factor analysis of their subjects' 16 VAS ratings at 12, 15 and 18 
hours after administration of the medication or placebo. The first 
factor was not significant but showed a trend while the second and 
third factors showed statistically significant (p < .05) and clear drug 
effects, indicating that the VAS sub-scales for "Calm/Excited" and 
"Contented/ Discontented" could measure drug effect. Although 
these authors did not use the more modern form of VAS their work 
implies an ability of the VAS to measure anxiety. 
Brown" studied 66 patients before and after either open surgery, 
percutaneous nephrolithotomy, or extracorporeal shockwave 
lithotripsy for renal calculi. She measured anxiety by palmar sweat 
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response, Spielberger State· Trait Anxiety Inventory (20 statements 
concerning present anxiety feelings ranked from 1 'not at all' to 4 
'very much so'), and the 1 00 mm VAS anchored at one end by a 
positive statement and at the other by a negative one. Using a t test 
a statistically significant decrease in palmar sweat response was 
noted between the open surgery group pre- and post-op (p < .001) 
coinciding with a similar statistically significant decrease in VAS 
ratings (p < 0.05). There was no such change in the Spielberger 
scores. There were non-significant reductions in scores for the three 
rating measures before and after the remaining two surgical 
treatments. The correlations between sweat responses and the other 
two measures of anxiety were poor. One conclusion was that 
palmar sweat responses measured state anxiety while the other two 
scales measured trait anxiety. This study hints at the use of the VAS 
to measure anxiety. 
Egan et a 1 " in 1992 reported on the effects of midazolam vs 
placebo on pre- and post<Qperative anxiety of forty women 
undergoing hysterectomy. The subjects were assessed for anxiety 
using the Spielberger Inventory and the 100 mm VAS for anxiety 
anchored by "No worry" and "Worst possible worry". They found 
lower scores in the midazolam group vs the placebo group as 
assessed by both scales (ANOVA p < .01). They did not report any 
direct correlations between the two scales. This indicates the VAS 
can measure drug-induced decrease in anxiety but offers indirect 
evidence that the VAS correlates with the Spielberger Index. 
Frattola et ai,7J studied the effects of an anxiolytic agent vs placebo 
in a double-blind randomized controlled trial with 40 anxious 
elderly out-patients. During the course of the study the subjects 
were repeatedly assessed for anxiety using the Hamilton Rating 
Scale for Anxiety (an interview style measure), the Spielberger State 
Trait Anxiety Inventory, and a 100 mm VAS anchored by "I feel 
alright and perfectly relaxed" and "I feel anxious and awfully tense". 
All three scales registered a decrease in anxiety scores for the drug 
vs the placebo groups (p < 0 .0023 to < 0 .016). The mean VAS 
score differences between the two groups were from 68.2 for 
placebo to 51.3 for the drug. The authors did not perform direct 
correlations between the VAS changes and those for the other 
measures. This study indicates the VAS can measure change in 
anxiety within subjects. 
Scott and Cadden" measured anxiety using the 100 mm VAS 
anchored by "No anxiety" and "As anxious as I can imagine" and 
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heart rate in 1 5 healthy volunteers who were part of a study on 
experimental pain induced by an electrical stimulus to the upper lip. 
The subjects recorded their anxiety after a block of ten such stimuli. 
The authors also recorded the reduction of masseter muscle 
inhibition induced by the electrical stimuli. Using at test the authors 
found statistically significant increases in both heart rate and VAS 
scores after the electrical stimuli as compared with the control 
period (p < .00005). They found a correlation between the 
reduction in masseter muscle inhibition and heart rate {r - -0.498; p 
< 0.01) but not between muscle response and the VAS (r - -0.196; 
p -0.3). The mean VAS scores increased from 16.4 mm to 56.7 mm 
while the heart rate increased from 70 to 80.7 beats per minute. The 
authors did not report any correlations between the heart rate and 
the VAS. This paper indicates that in experimental pain situations 
the VAS can measure change in anxiety, and correlates acceptably 
with some of the physical concommitants of anxiety. 
Using the Hamilton Rating Scale for Anxiety, the Self-rating 
Depression Scale and the 100 mm VAS anchored by "Well being" 
and "Uneasiness" laakman et a1 75 studied the response of 
amitriptylline, alprazolam, lorazepam, or placebo on the anxiety of 
197 depressed out-patients. All three scales measured a decrease in 
anxiety (p < 0.05) in the drug groups vs the placebo group. No 
correlations between the scales and the VAS were reported. The 
mean VAS scores decreased between 30 lSD 16) and 34 lSD 27) 
mm for those subjects treated with active medications. This study 
offers evidence that the VAS measures change in anxiety within 
subjects who are depressed but does not indicate how the VAS 
correlates with other well used anxiety measures. 
Penttila et a1 76 compared the reduction in pre-operative anxiety 
induced by either diazepam or triazolam in 81 subjects awaiting 
elective surgery. The authors measured this reduction using a 50 
mm VAS card and the anesthesiologists' evaluation on a 4 point 
scale (relaxed, minor, moderate, or severe anxiety). The authors 
used t tests to establish significant reductions in anxiety for the 
triazolam group from baseline as recorded by the anesthesiologists 
(p - .004) and the VAS (p - .002). No correlations of scores 
between the two scales were recorded. This study indicates the 
ability of the VAS to measure change in anxiety within subjects. 
As part of a larger study on medications to reduce experimental 
anxiety Hetem et a 1 77 induced anxiety in 43 healthy subjects by 
two methods; public speaking (a well known elevator of anxiety) 
so 
simulated by talking to a video camera, and by an aversive white 
noise. The investigators measured heart rate, blood pressure and 
anxiety using the Spielberger State-Trait Anxiety Inventory and a 
collection of 16 100 mm VAS measures. Using a MANOVA 
procedure the authors found both tests measured significant 
increases in induced anxiety, VAS of anxiety F- 17.46, p <.001), 
Spielberg (F - 37.26, p < .001 ). They also found increases in 
systolic (F - 11.S9, p < .001) but not diastolic blood pressure and 
no significant changes in pulse rate in response to the induced 
anxiety. This study offers evidence that the VAS measures change in 
induced anxiety within subjects. 
While trying to evaluate the predictors of cooperation during 
gastrointestinal endoscopy in 251 outpatients, Mahajan and 
company.-7 measured anxiety using five procedures: 1) a single 
question to the subject about immediate anxiety scored as: not at 
all, slightly, moderately, or excessively, 2) a modified Hospital 
Anxiety and Depression Scale, 3) a tOO mm VAS anchored by "No 
anxiety" and "Maximal anxiety", 4) an endoscopist's rating of 
cooperation (excellent, good, fair, or poor) and 5) two Patient 
Comfort Scales (patient satisfaction questionnaires completed 24 
hours after the procedure). The Spearman correlation coefficients of 
the endoscopist's ratings and the various anxiety measures were as 
follows: single question, rho - 0.139 ( p < 0.031; VAS rho -
0.147, p < 0.02), the modified Hospital Scale, rho - 0.117 (p NS); 
and Patient Comfort Scales were not statistically significant. The 
authors found statistically significant, but weak, correlations between 
the patient's willingness to undergo a repeated endoscopy (part of 
the Patient Comfort Scale) and the single question (r -0.148, p 
<.02), the VAS (r -0.195, p <.002), and the modified Hospital 
Scale (r - 0.170, p< .007). These authors' statistical computations 
show very weak although statistically significant correlations 
between trained observer ratings and VAS measured anxiety, and 
between the Patient Comfort Scale and the VAS and may indicate 
the VAS as an appropriate scale for measuring anxiety between 
subjects. 
3.7.3 SUMMARY 
Given that some of the above authors offer acceptable correlations 
between this scale and other measures, the VAS appears acceptable 
as a measure of anxiety. 
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3.8 TIREDNESS 
3.8.1 CANCER-RELATED TIREDNESS 
Smets et a1" developed the Multidimensional Fatigue Inventory, a 
twenty item self-report questionnaire consisting of the following 
sub-scales: general fatigue, physical fatigue, reduced anxiety, reduced 
motivation, and mental fatigue, which they compared with a 100 mm 
VAS anchored by "Not at all tired" and "Extremely tired." They studied 
111 cancer out-patients receiving radiotherapy, 357 out-patients 
suffering from a chronic fatigue state, 481 healthy university students, 
158 healthy medical students, 46 healthy junior physicians, and 160 
healthy army recruits. They calculated a significant internal consistency 
of their inventory (Cronbach's alpha < 0.80 in most sub-scales), and 
significant construct validity (univariate analyses of variance between 
sub groups of subjects as p < .001). They concluded their inventory 
measures fatigue and can distinguish between subjeds based on levels 
of fatigue. Significant correlation coefficients between all the sub-scales 
and the VAS were reported including general fatigue (r -0.77, p 
< .001). 
Using their inventory, as reported above, and a 100 mm VAS, the 
same group79 studied 134 cancer out-patients who were receiving 
radiotherapy. They calculated significant correlation coefficients 
between the VAS scores and all the separate sub-scales including 
general fatigue (r - 0.83, p < 0.001 ). Both these works offer strong 
support for the use of the VAS as a valid screening tool to measure 
fatigue and to distinguish between subjects based on their level of 
fatigue. 
3.8.2 NON CANCER-RELATED TIREDNESS 
Wigers80 reported on a study of 44 fibromyalgia out-patients who 
were followed for four and one half years after the invitation to 
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participate in an exercise program. The author assessed pain, disturbed 
sleep, depression, and lack of energy using separate 1 00 mm VAS 
ratings anchored by "Nothing" and "The worst you have ever 
experienced," as well as physical adivity level (adequate/other), 
disability pension (full/other), symptom duration, and negative life 
events ( > 2/others). By multiple regression analysis the VAS for lack of 
energy was compared wi th activity level (standardized correlation 
coefficient - 0.6, p <.0001), with disability pension (standardized 
correlation coefficient - 0.3, p < .01), and with negative life events 
(standardized correlation coefficient - 0.3, p < 0.05), the regression 
r - .58 while F - 8.6. Symptom duration demonstrated poor 
correlations. The correlation between the VAS and physical adivity is 
moderate indicating the usefulness of the VAS to measure tiredness. 
3.8.3 SUMMARY 
Although not as well studied as the VAS for pain, nausea, depression, 
and dyspnoea the VAS for tiredness appears to be an acceptable and 
valid means of measuring tiredness. 
3.9 DROWSINESS 
There appear to be numerous articles available wherein the VAS is 
used to measure sleep either in quantity or duration but these do not 
truly reveal much about drowsiness. The term drowsiness itself is 
somewhat confusing when juxtaposed with tiredness: the former might 
suggest sleepiness or somnolence, while the latter could imply apathy 
or listlessness. Still, a review of the available literature revealed the 
vast majority of the research articles that discuss the use of the VAS for 
drowsiness do so in its context as a measurement tool with very little 
in the way of justification through referenced validation studies. 
3.9.1 CANCER-RELATED DROWSINESS 
Faithful!" described, in 7 cancer patients who had undergone cranial 
radiotherapy, the somnolence syndrome consisting of excessive sleep, 
lethargy and anorexia. The drowsiness was rated using a series of 100 
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mm VAS scales anchored by the following seven descriptor pairs: 
"Alert/ Drowsy", "Muzzy/ Clear-headed", "Lethargid Energetic", 
"Attentive/ Dreamy", "Mentally Slow/ Quick-witted", "Strong/ Feeble", 
and "Interested/ Bored". The subjects also kept daily diaries and gave 
open ended interviews of their feelings. Because of the small numbers 
and qualitative nature of the diaries and interviews, quantitative 
analyses were not possible. She did offer a review of the use of the 
VAS suggesting that it has been well validated. 
3.9.2 SUMMARY 
The use of the VAS to quantify drowsiness has not been well studied. 
3.10 APPETITE 
Rabin and colleagues82 measured hunger and satiety with a 10 em 
VAS, food consumption, and serum glucose and lactate levels in 9 
healthy subjects before and after two test meals. Using coefficients of 
repeatability they found large variations between the mean scores for 
all their measures before and after the test meals. They concluded that 
the wide variations of appetite ratings by the VAS should not be 
interpreted as a failure of the VAS but rather that hunger and satiety 
were not solely dependant on serum glucose levels. 
Indirect evidence of the ability of the VAS to measure change within 
subjects comes from Beal et al" who offered 139 AIDS patients with 
weight loss either Dronabinol or placebo. Those taking the active agent 
gained weight, felt better and demonstrated, with the use of t tests, 
statistically significantly higher scores (p < 0.015) for VAS measured 
appetite. 
One must proceed here with caution; the VAS was used to measure 
the difference of any effect exerted by the active agent over placebo so 
conclusions about the validity of the VAS being able to measure 
change in appetite based on the lack of response to placebo could be 
problematic. 
3.10.1 SUMMARY 
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The use of the VAS to measure appetite has not been well studied. 
3.11 WELL BEING 
There appears to be little or no research into the use of a single VAS 
to rate overall well being. 
3.12 OVERALL SUMMARY 
The VAS is well val idated as a tool to measure subjective feelings. Six 
symptoms: pain, mood, dyspnoea, anxiety, nausea, and tiredness have 
been well studied and the VAS has been validated as an appropriate 
measurement tool for their quantification; while the three symptoms of 
appetite, overall well being and drowsiness are not well enough 
studied, according to the literature search reported here, to determine 
if they are accurately rated by the VAS. 
3.13 CHOICE OF MEASUREMENT INSTRUMENT 
In any study involving sick people a measurement tool must have three 
qualities: be easy to understand and use, be able to measure what it 
reports to measure, and be quickly done. As has been demonstrated 
above the VAS meets these three criteria. 
Of the symptoms listed in Table I (page 3) the following nine will be 
studied as they appear, to the author, to be the most clinically 
important and are those measured by the Edmonton Symptom 
Assessment System (ESAS): pain, nausea, tiredness, drowsiness, 
dyspnoea, appetite, depression, anxiety, and well being. 
The instrument used was the Edmonton Symptom Assessment System 
or ESAS (Section 2.6, page 18) which is comprised of nine 100 mm 
VAS defining the nine symptoms listed above. Because of its ease of 
comprehension, the short time taken to complete, the validity of most 
of the sub-scales, and its clinical application this instrument appeared 
the most appropriate for this study. 
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CHAPTER IV 
RESULTS OF THE STUDY 
4.1 QUALITY CONTROL OF DATA 
Quality control was assessed by comparing the measurements of the 
raw ESAS scores, made by the principal investigator (BE), with those of 
a second investigator UH). A random sample was seleoed of 10 
patient\family member\nurse triads, consisting of 9 VAS measures per 
subjed and three subjeds per triad for a total of 270 measurements. 
Kappa could not be computed using the 100 mm scale because at least 
one of the cells of the crosstable was empty and SPSS for personal 
computer could not therefore determine this statistic. 
When the raw scores were converted to a ten point scale the Kappa 
between the two investigators' measurements of the VAS data was 
high: k - 0.96 (p < 0.001 ), indicating that the primary investigator's 
measurements of the raw VAS data were accurate. 
4.2 DEMOGRAPHIC RESULTS 
352 patients were recorded in the ward log book, between September, 
1997 and February, 1998 as eligible to enter th is study, with 100 
patient/family/nurse triads completing the protocol. As can be seen in 
Table IV only 28.4% of apparently eligible patients were enrolled 
while 17.3% refused and 11.3% were deemed too confused to 
participate. Of those who did not participate 43% were in the 'other' 
category meaning they were either too ill to be approached by the 
charge nurse, were too busy to be interviewed by the investigator, had 
no family members available, or were discharged before they could be 
interviewed. 
Sixty-four nurses participated as subjeos in this study. All except one 
were female. No other information about these nurses, such as years 
since graduation, status concerning certification from the Canadian 
Association of Nursing Oncology, age, or years in present job was 
recorded. The five charge nurses have all been employed as nurses for 
at least 1 5 years each and are considered senior and experienced. 
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TABLE IV: DISTRIBUTION OF ELIGIBLE AND ENROLLED 
PATIENTS BY HOSPITAL LOCATION 
Ward Total Con- Refuse Con- Refuse Other Total 
Eligib. fusion To fusion To En-
RN RN Invest Invest- rolled 
Assess Assess igator 
4NA 227 12 10 4 23 116 62 
6 East 89 10 11 2 9 26 31 
PCU 36 10 5 2 3 9 7 
Total 352 32 26 8 35 151 100 
%Total 100 9 7.3 2.3 10 43 28.4 
The breakdown of this 'other' category by percent of total patients 
potentially eligible and by hospital ward reveals the following: PCU 
25%, 6 East 29°/o, and 4NA 51%. Many of the patients on 4NA were 
admitted for the administration of chemotherapy and were 
consequently often too ill to participate. Once the therapy had finished 
the patients were quickly discharged and therefore unavailable for 
interview. Also 4NA is the major provincial referral site for 
haematological malignancies and many of the patients came from far 
away without any family members. The breakdown into these three 
categories: too sick, early discharge, no family present, was not 
recorded during the data colledion. 
TABLE V: NATURE OF THE RELATIONSHIP BETWEEN THE 
FAMILY MEMBER AND THE PATIENT 
Family Member Number of Subjeds (n - 1001 
Spouse 57 
Adult Child 16 
Sibling 14 
Parent 7 
Other Relative 4 
Friend 2 
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TABLE VI: LOCATION OF RESIDENCE OF FAMILY 
MEMBERS IN RELATION TO THE PATIENT 
Location of Residence of Family Member Number of Subjects 
{n - 100) 
Same House 69 
Same City 16 
Distant Community 15 
The mean age of the patient subjects was 54.9 years with a range of 
22 to 88 years, median age was 57 years. Sixty-one percent of the 
patient subjects were female: 39% male. The ward locations of the 
patients are shown in Table IV. Table V displays the relationship 
between the patients and their next of kin, while Table VI indicates 
where the next of kin lived in relation to the patient. Table VII lists 
the frequency of diagnoses of the patient subjects. 
TABLE VII: TYPE AND FREQUENCY OF 
MALIGNANCY IN THE STUDY SUBJECTS 
TYPE OF MALIGNANCY FREQUENCY {%) 
Leukaemia 24 
Colon 17 
Lymphoma 14 
Breast 11 
Lung 8 
Stomach 6 
Gynaecologic 7 
Other G.\. 4 
Other 6 
Missing 3 
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4.3 STATISTICAL RESULTS 
Table VIII shows the means, standard deviations, and t scores with 
significance testing, of any differences of the ratings, for each of the 
ESAS sub-scales done by the patient and family member. At a 
confidence level of 95% the family members rated the patients' 
sensation of well-being as worse than did the patients, while no 
differences were detected for ratings of the remaining 8 symptoms. 
TABLE VIII: MEAN E.S.A.S SCORES (in 
BY THE PATIENT AND 
DEVIATIONS, t SCORES, 
SIGNIFICANCE LEVELS 
mm) AS RATED 
FAMILY,STANDARD 
AND STATISTICAL 
Symptom Patient (501 Family (50) t score Statistical 
Significance 
Appetite 42.1 B (34.821 45.49 (34.86) 0.99 0.32 
Well Being 37.36 (28.17) 44.95 (34.86) 2.32 0.02 • 
Tiredness 34.01 (27.49) 37.73 (27.44) 1.53 0.13 
Drowsiness 26.98 (26.761 24.94 (24.91) -0.92 0.36 
Anxiety 26.32 (26.76) 30.77 (27.12) 1.67 0.1 
Dyspnoea 21.28 (24.65) 22.96 (26. 94) 0 .59 0.6 
Depression 18.17 (22.79) 20.13 (22.8) 0.76 0.45 
Nausea 17.66 (25.27) 14.65 (19.88) -1.73 0.09 
Pain 16.32 (15.22) 19.88 (20.04) 1.76 0.08 
SignifiCant d1 erence IP < u. '51 
Appendix VIII contains the scatter diagrams, with line of best fit, that 
show any linear relationship that might exist between the perceptions 
of the patient and family member and between patient and nurse for 
each of the nine symptoms assessed. These scatter diagrams illustrate 
that the statistically significant or non-significant differences, as 
demonstrated by the t - test, are true differences; and that any 
agreements, as demonstrated by Cohen's Kappa, are true agreements; 
and that no other relationship exists between the symptom perceptions 
of the patient\ family\ nurse triads. 
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TABLE IX: MEAN E.S.A.S. SYMPTOM SCORES (in mm) AS 
RATED BY PATIENT AND NURSE, STANDARD 
DEVIATIONS, t SCORES, AND STATISTICAL 
SIGNIFICANCE LEVELS 
Symptom Patient (50) Nurse (50) t score Statistical 
Significance 
Appetite 42.18 (34.82) 47.21 (24.311 1.36 0.18 
Well Being 37.36 128.17) 47.45 (21.14) 2.71 0.01 • 
Tiredness 34.01 127.49) 40.12 (23.00) 2.02 0.05' 
Drowsiness 26.98 (26.76) 24.67 (24.39) -0.74 0.46 
Anxiety 26.32 (26.76) 32.28 (23.06) 1.79 0.08 
Dyspnoea 21.28 (24.65) 12.56 (18.75) -3 .18 0.002' 
Depression 18.17 (22.79) 28.44 (22.98) 3.45 0.001' 
Nausea 17.66 (25.271 21.74 (25.94) 1.68 0.1 
Pain 16.32 (15.22) 26.92 ( 23.42) 4.11 0.01' 
Slgnt 1cant m erence IP < O.C5) 
Table IX shows the means, standard deviations, and significance of any 
differences of the ratings for each of the ESAS sub-scales done by the 
patient and nurse. At a confidence level of 950fo the nurses' ratings 
were different from those of the patient for five of the nine symptoms: 
over-estimations for the lack of well being, tiredness, pain, and 
depression; and under.-estimation of the patients' perceptions of 
dyspnoea. 
Using the ten point (10 em) scale, 7 out of the 18 kappa calculations 
could not be computed using SPSS for personal computer. 
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TABLE X: AGREEMENT !KAPPA) BETWEEN PATIENT AND 
FAMILY MEMBER AND BETWEEN PATIENT AND 
NURSE ON ESAS SCORES FOR A THREE POINT 
SCALE 
Symptom Kappa (significance) Kappa (significance) 
Patient and Family Patient and Nurse 
Appetite 0.43 (0.001) O.OS (0.4) 
Well Being 0.19 (0.007) 0.06 (0.38) 
Tiredness 0.35 (0.001) 0. 10 (0.17) 
Drowsiness 0.32 (0.001) 0.21 (0.006) 
Anxiety 0.25 10.005) 0.03 (0.72) 
Dyspnoea 0.16 (0.03) 0.19 (0.01) 
Depression 0.45 (0.001 I 0.08 (0.28) 
Nausea 0.43 (0.001) 0.28 (0.001) 
Pain N/C N/C 
ee text or ae 1n ttl on o t e t ree potnt scale 
Kappa: 0 to 0.35 - poor agreement, 0.35 to 0.5 - moderate 
agreement, 0.5 to 0.75 - strong agreement 
Table X shows the Kappa as calculated using the three point scale and 
demonstrates that family members agreed with the patient on four of 
the eight symptoms (appetite, tiredness, depression and nausea) for 
which this statistic could be calculated, while the nurses showed poor 
agreement for all of these eight symptoms. The family members did not 
agree with the patient on the ratings of well being, drowsiness, anxiety, 
and dyspnoea. Because no patients rated their pain as 'severe' (over 60 
mm on the Pain VAS), those cells of the cross-table were left empty 
which precluded the calculation of the Kappa statistic by SPSS for 
personal computer. 
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TABLE XI: 
Symptom 
Appetite 
Wellness 
Tiredness 
Drowsiness 
Anxiety 
Dyspnoea 
Depression 
Nausea 
Pain 
AGREEMENT (KAPPA), AND PERCENT 
AGREEMENT BETWEEN PATIENT AND FAMILY 
MEMBER AND BETWEEN PATIENT AND NURSE 
ON ESAS SCORES FOR A BINOMIAL SCALE 
Kappa (significance) Kappa (significance) 
and Percent Agreement and Percent Agreement 
Patient and Family Patient and Nurse 
0.44 (0.001) 71% 0.11 (0.26) 55% 
0.29 (0.003) 54% -0.07 (0.44) 45% 
0.47 (0.001) 75% 0.11 (0.24) 55% 
0.44 (0.001) 77% 0.17 (0.08) 66% 
0.44 (0.001) 75% 0.13 (0.16) 62% 
0.28 (0.004) 75 % 0.11 (0.26) 75% 
0.34 (0.00 1) 78% 0.05 (0.59) 63% 
0.56 (0.001) 90~. 0.42 (0.00 1) 82% 
0.3 (0.001) 84% 0.04 (0.6) 71% 
ee text tor detin1t10n ot the bmom1a scale 
Kappa: 0 to 0.35 - poor agreement, 0.35 to 0.5 - moderate 
agreement, 0.5 to 0.75 - strong agreement 
Table XI displays the results using the binomial scale, the family 
members' ratings demonstrated moderate or strong agreement with 
those of the patients on five of the nine symptoms: appetite, tiredness, 
drowsiness, anxiety, and nausea. The nurses agreed with the patient on 
the perception of only one of the nine symptoms: nausea. 
The family members did not agree with the patient on the ratings of 
well being, dyspnoea, depression, and pain. Table XI also shows the 
percent agreement between patient and family member and between 
patient and nurse. This indicator ranged from 45% to 90%. 
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TABLE XII: 
Symptom 
Appetite 
Wellbeing 
Tiredness 
Drowsiness 
Anxiety 
Dyspnoea 
Depression 
Nausea 
Pain 
Kho: o to U.25 
correaltion 
CORRELATION ( SPEARMAN ' S rho) 
BETWEEN SYMPTOM RATINGS OF 
PATIENT AND FAMILY AND BETWEEN 
PATIENT AND NURSE ON ESAS SCORES 
FOR A 1 DO POINT SCALE 
rho (significance) rho (significance) 
Patient and Family Patient and Nurse 
0 .54 (0.001 ) 0.23 (0.2) 
0.37 (0.001) -Q.2 (0.86) 
0.61 (0.001) 0.29 (0.003) 
0.55 (0.001) 0.23 (0.D2) 
0.49 (0.001) 0.19 (0.06) 
0.42 (0.001) 0.31 (0.002) 
0.47 (0.001) 0.23 (0.02) 
0.56 (0.001) 0.37 (0.001) 
0.46 (0.00 1) 0.28 (0.005) 
-
no correlation, 0.25 to 0.50 
-
moderate 
0.50 to 0.75 - strong correaltion, > 0 .75 - very strong 
correlation 
Table XII displays the results of the Spearman's Rank Order Correlation 
(rho) calculations for the full data set using the 100 mm scale. SPSS for 
personal computer can calculate rho without the technical problems 
found with the calculation of Cohen 's Kappa; so the whole, 
unmodified, data can be used for the determination of this statistic. 
There was strong correlation (rho > 0.50) between patient and family 
members on the ESAS scores for four of the nine symptoms: appetite, 
tiredness, drowsiness and nausea, and moderate correlation (rho > 
0.25) forthe remaining five symptoms: well-being, anxiety, dyspnoea, 
depression, and pain. 
Also Table XII shows that, for the full data set, the nurses' ESAS scores 
showed four of the nine symptoms: nausea, pain, tiredness, and 
dyspnoea to have moderate correlations (rho > 0.25) w ith those of the 
patient, and none to have strong correlations (rho > 0.50). 
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TABLE XIII: CORRELATION (SPEARMAN'S rho) BETWEEN 
SYMPTOM RATINGS OF PATIENT AND FAMILY AND 
BETWEEN PATIENT AND NURSE ON ESAS SCORES 
FOR A BINOMIAL SCALE 
Symptom rho (significance) rho (significance) 
Patient and Family Patient and Nurse 
Appetite 0.51 (0.001) 0.11 (0.3) 
Wellbeing 0.30 (0 .0031 -0.08 (0.41 
Tiredness 0.48 (0.001) 0.12 (0.21 
Drowsiness 0.44 (0.001) 0.17 (0.08) 
Anxiety 0.46 (0.001) 0.14 (0.2) 
Dyspnoea 0.29 (0.004) 0.11 (0.31 
Depression 0.35 (0.001) 0.05 (0.6) 
Nausea 0.58 (0.001) 0.43 (0.001 I 
Pain 0.32 (0.001) 0.05 (0.6) 
{ho: 0 to 0.25 
-
no correlation, 0.25 to .so - moderate 
correaltion 
0.50 to 0.75 - strong correaltion, > 0.75 - very strong 
correlation 
Table XIII displays the Spearman's rho correlations between patient and 
family and between patient and nurse using the ESAS data manipulated 
to produce scores of a binomial nature: using, as in Table XIII, the VAS 
cut-off of 40 mm within the 100 mm scale. 
The family members' ESAS scores showed strong (rho > 0.501 
correlations with those of the patient for the two of the nine symptoms: 
appetite and nausea, and moderate correlations (rho > 0.25) the 
remaining seven symptoms. The nurses' ESAS scores showed a 
moderate correlation (rho > 0.251 with those of the patient for only 
one of the nine symptoms: nausea, and no strong correaltions. 
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CHAPTER V: DISCUSSION OF RESULTS 
5.1 INTRODUCTION 
This chapter will begin with a discussion of recruitment concerns, 
followed by discussions of demographic matters and statistical 
considerations. The results of the present study will be compared with 
the findings of previous studies, those discussed in Chapter I and 
summarized in Table II (page 6). Table XIV (page 69) shows those 
same studies referred to in Table 11 with the addition of statistical 
methods used. 
5.2 RECRUITMENT ISSUES 
The charge nurses for each ward kept a study log book into which the 
names of the patients currently under their care were recorded. 
Although the investigator presented himself to the ward or spoke to the 
charge nurse every week-day of the study period not all eligible 
patients were recorded either because they were admitted and 
discharged before the charge nurse met them (ie. weekend or short 
stay admissions, or transfers off the ward soon after admission), or the 
charge nurse was too busy to approach the patient concerning 
participation. 
Although the numbers of those patients who were missed are not 
known, 4 North A and the PCU had discharge books, completed after 
the patient was sent home, which the investigator reviewed in order 
to ensure all admitted, eligible patients were recorded in the research 
log books. On 6 E the charge nurse recorded only those patients who 
were assessed at the bedside; which included those too ill to 
participate, those who refused, and those who agreed to meet the 
investigator. The investigator reviewed the patient list, daily, to capture 
the names of those eligible patients who were over-looked by the 
charge nurse. As the medical records departments list discharges from 
the hospital but not transfers to other wards, these departments could 
not further define the numbers of eligible patients any better than the 
investigator's methods of recording all eligible subjects. 
The recruitment process was open to selection bias in that the charge 
nurse's primary duty was to protect the privacy and welfare of her 
often quite ill patients rather than collect subjects for research 
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purposes. If a patient or family member was upset or angry the nurse 
would exclude the patieot from the study by not asking the patient and 
family to consider participation. The threshold in clinical nurses for 
making these judgements will vary among and between nurses, and 
was not assessed formally during this research. If such patients were 
angry or upset because of family issues the overall study agreement 
between patient and family on symptom assessment might be less 
because, or might be an indication of this conflict. 
On some wards on some days all of the patients except those who 
were markedly confused or in severe distress were invited to 
participate while on other days the situation was less advantageous to 
recruitment. The work load of the charge nurses seemed to be the 
predominant factor here, although this was not formally assessed. 
In preparation to begin this study, the investigator calculated, from data 
supplied by the medical record departments of the two hospital sites, 
the average weekly discharge rate for eligible patients. That rate was 
twenty-two patients per week. Over the study period of sixteen weeks, 
between September, 1997 and February, 1998; the expected number 
of discharges was 352, the same number as those recorded as eligible. 
As the expected number of patients was so close to the recorded 
eligible patients there appeared to be few eligible patients who missed 
the opportunity to consider participation in this study. 
Table IV (page 57) shows that of the 352 patients available for 
recruitment 151 were recorded as "other" indicating they were, in the 
opinion of the charge nurses, either; too ill, too distressed, or had 
families that were too distressed; or just over-looked. The percent 
breakdown of those eligible, by hospital ward location, of this "other" 
category reveals the following: PCU 25%, 6E 29%, and 4NA 51%. The 
intense work load of the charge nurses mitigated against a further 
breakdown of this "other" category, into the sub-groups of too 
distressed, no relatives, over-looked, or discharged too soon to be 
approached. 
The high frequency of patients, on 4 NA, in this "other" category 
deserves mention: Table VIII (page 59) shows that 38% of the study 
subjects (73% of those subjects from 4NA) were suffering from 
leukaemia or lymphoma. As 4NA is the provincial referral centre for 
the treatment of haematological malignancies many of the patients 
there are repeatedly admitted for the administration of 
chemotherapeutic agents which are likely to have side effects 
unpleasant enough to inhibit patients from volunteering to enter a 
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study such as the present one. By the time such patients begin to 
recover they are often quickly discharged to make room for other 
patients waiting for similar treatment. Although many patients were 
recorded as eligible to participate they were either too ill or were 
discharged before they could be approached to participate. Also once 
the first couple of treatments of chemotherapy have been completed 
the out-of-town patient may feel comfortable enough with the situation 
to arrive alone for subsequent treatments. In other words, because the 
family members were not available for interview the patient was 
excluded. 
Some of the family members of eligible patients appedred, in the 
opinion of the charge nurse, unduly distressed by anger, frustration, or 
sadness. In such situations the patient was not approached in an 
attempt to decrease, or at least not inflame, the family distress. The 
numbers of such situations were not recorded. 
Table IV (page 57) demonstrates that as many patients as were studied 
(100) were either confused (40) or refused (61). This is not surprising 
as many of the eligible patients were in physical distress, emotionally 
frail. or quite incapacitated due to advanced disease or as a result of 
treatment; none of which is conducive to voluntarism in even the 
shortest of research projects. Of those confused, 32 were so deemed 
by the charge nurse while 8 more were rejected because of low scores 
on formal mental status testing. 
It is possible that the sicker more distressed patients were not invited 
to participate based on the feelings of the charge nurses; certainly for 
pain, nausea, shortness of breath, tiredness, and drow siness the 
subjects in the studies listed in Table XIV (page 69) rated their 
symptoms as more severe than did the subjects in the present study. 
The conclusion: that the family members agree with the patient on 6 
of the 9 symptoms of the ESAS, may be limited to those patients with 
low symptom severity ratings. However there was strong agreement 
between patient and family on the subject of poor appetite where the 
mean symptom severity rating was relatively high at 42.18 mm. 
5.3 DEMOGRAPHIC ISSUES 
As shown in Table VI (page 58), 57% of the family members were 
spouses, which is similar to the 60% to 78% noted in the studies listed 
in Table II, while the proportion who lived with the patient (Table VII , 
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page 58) was similar as well. 
As shown in Table V111 (page 59) 38% of the subjects were afflicted by 
haematological malignancies which is much higher than those studies 
listed in Table II that report on the malignancies suffered by their 
subjects. This is not a major concern as the object of this study was to 
compare agreement of symptom perceptions and haematological 
malignancies create a constellation of symptoms as unpleasant as 
other malignancies. 
Apart from the high proportion of patients wilh haematological 
malignancies the subjects in the present study appear comparable with 
those subjects in previous studies, indicating that the results and 
conclusions from the present study are applicable to hospitalised 
patients suffering from cancer. 
5.4 STATISTICAL ISSUES 
The means and standard deviations of the ESAS data, shown in Tables 
VIII and IX (pages 59, 60), are listed in descending order. The means 
are unique to this group of subjects and can vary from those means of 
other subject cohorts depending on the severity, duration, and stage of 
the cancer experience. Table XIV (page 69) shows the mean symptom 
scores, where the VAS was used and where the scores were provided, 
for those studies listed in Table II. The wide standard deviations of the 
VAS scores of the present study indicate that the raw scores are not 
normally distributed, and that the subjects offered a wide range of 
responses. The standard deviations form the present data are not unlike 
those found in the studies listed in Tables II and XIV. 
Ideally the kappa statistic should have been calculated using the 1 00 
mm scale but, as mentioned above, SPSS for personal computer will 
not compute this for the present data set. There were no patient ratings 
of pain above 60 mm so even using the three point scale the kappa 
statistic could not be calculated for this symptom. 
The kappa and rho for the binomial ESAS data were calculated to be 
almost the same; indicating, perhaps, that both are measuring the same 
thing. Both tests confirmed the same symptoms on which the family (5 
of 9 for kappa and 6 of 9 for rho) and nurses (1 of 9) concorded with 
the patient. Spearman's rho for the 100 mm raw data is, perhaps, a 
closer reflection of the true state of things than the rho calculated using 
the binomial data because of the greater sensitivity of the larger scale 
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to measure correlation in symptom ratings. 
TABLE XIV: STUDIES ON THE RELATIONSHIP BETWEEN CANCER 
PATIENTS' PERCEPTIONS OF THEIR SYMPTOMS AND 
THE PERCEPTIONS OF THEIR FAMILY MEMBERS AND 
NURSES: STATISTICS USED, AND MEAN PATIENT 
SYMPTOM SCORES 
Study Relation Symptom Statistical Pt ,\;\ean % 
to Assessed Tests Symptom Agree 
Patient Score 
(50) 
Lobchuck Family Multiple Kappa 59 (24) 44"/o 
to to 
34 (171 65% 
Ferrell Family Pain t-test 53 (291 N/A 
to 
35 (261 
Clipp Family Pain Correl- N/A 48% 
Depress at ions 43% 
O'Brien Family Pain Kappa N/A 54% 
Madison Family Pain Rho 32.1 22% 
(30.81 
Yeager Family Pain t-test 41.7 (401 N/A 
Miaskowski Family Pain t-test N/A 29.5 
% 
Ferrell Family Pain t-test 52 N/A 
Holmes Nurse Multiple t-test N/A 6% 
Correl- to 
ations 20% 
Grossman Nurse Pain Pearson 34 7% to 
82% 
Eaton Family Multiple Kappa 16 (151 45% 
Nurse rho, t-test to to 
42 (351 90% 
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Although the values for rho and k for the binomial data are virtually 
the same, correlation does not always mean agreement and, because 
the purpose of the present study was to measure agreement, the kappa 
from the binomial data was used to draw the final conclusions about 
the way cancer patients, their families, and their nurses perceive 
symptoms. The calculated rho's were used to confirm or buttress the 
kappa statistical results. 
The scatter diagrams found in Appendix VIII would show a slope of 
45" and a y intercept of 0 if perfect one-to-one agreement existed. The 
further away from these ideals the less agreement. The scatter diagrams 
also show that no other linear relationships exist w ithin those 
symptoms where the t-test shows statistically significant difference 
between raters. 
5.5 COMPARISONS WITH PREVIOUS STUDIES 
As shown in Table XIV the percent agreement between nurse and 
patient, in previous studies, on symptom rating was between 6% and 
82% while Table XI (page 621 shows that for the present study the 
agreement was between 45% and 82%. For family members the 
equivalent numbers are between 22% and 65%, for previous studies, 
and between 54% and 90% for this study. Although the family 
members in the present study are closer in percent agreement with the 
patient than has been reported by other authors, percent agreement has 
little meaning really because the range of percent agreement for the 
same Kappa can vary widely, as can the range of Kappa for any given 
percent agreement. 
5.6 PAIN 
5.6.1 PATIENT AND FAMILY 
All of the nine studies listed in Table XIV involving cancer patients and 
their family members compared the subjects' perceptions of pain. Two 
researchers (lobchuck, O'Brien) used the Kappa statistic to assess 
agreement between family members' and patients' perceptions of pain. 
The Kappas of 0.31 and 0.24, indicating low levels of agreement, 
closely correspond to the Kappa of 0.30, using the binomial data set, 
found in the present study. 
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Two groups (Madison, Clipp) used correlation statistics to assess 
concordance of pain perceptions. Rho in the first study was 0.27 for 
total pain scores; while, in the second, r was 0.55 with 48% 
agreement, indicating low to moderate agreement which mirrors the 
findings of the present study where rho was 0.46 for the full data set 
and 0.32 for the binomial data with 84% agreement. 
Five authors (Ferrell 1995, Curtis, Yeager, Miaskowski, Ferrell 1991) 
reporting on the difference between patient and family perceptions, 
used the t-test to provide statistical demonstration of this difference. 
The mean pain VAS scores, scored out of 1 00 mm, of the patients 
ranged from 24.1 mm to 59 mm. Three of the studies 1221 subject 
dyads) found statistically significant over-estimation of the patients' 
pain by the family members; while two studies (101 subject dyads) 
found statistically significant under·estimation by the family. In the 
present study the mean patient pain score was 16.32 while the mean 
family pain score was 19.88, however the t-test demonstrated no 
statistically significant difference. 
The subjects in the present study reported much less pain than did 
those from other studies indicating, perhaps, that the patients in the 
present study were not as ill. With poor agreement, conflicting 
correlations and mixed differences in perceptions reported in previous 
studies, the low kappa and non significant t-test found in the present 
study data are not surprising. Taking all the results into consideration, 
there appears to be no consistent evidence that family members 
perceive pain the same as the patients. 
5.6.2 PATIENT AND NURSE 
Two studies compared the ratings of cancer-related pain by the patient 
and the nurse. Grossman (103 subjects) reported a correlation of 0.46 
(p < 0.000 1) between both groups, the mean pain scores (out of 1 00 
mm) were 34 mm for the patient and 24 mm for the nurses but no tests 
of significance for this difference were carried out. Holmes (53 
subjects) reported that 14 nurses under-estimated, 5 agreed with, and 
34 over-estimated the patients' ratings: the t-test was significant (p < 
0.05) for over-estimation by the nurses. In the present study rho for the 
full data set was 0.29 (p < 0.005) and 0.05 (p < 0.6) for the binomial 
data set. While rating symptoms on a 1 00 mm scale, the nurses (26. 92 
mm) over-estimated the patients' (16.32 mm) pain, (p < 0.01 ). Again, 
as with the family members, there appears to be no consistent 
evidence that nurses perceive pain the same as the patient. 
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5.7 SHORTNESS OF BREATH 
5.7.1 PATIENT AND FAMILY 
Lobchuk (37 subjeds) calculated the agreement, using the Kappa 
statistic, between patient and family for ratings of dyspnoea as 0.41 (p 
- 0.01) indicating moderate agreement; while the mean pain ratings 
were not significantly different, patient 2.22 and fami ly 2.47 (scored 
out of 5 using a Likert scale). The equivalent Kappa found in the 
present study was 0.28 (p - 0.004), indicating weak agreement; while 
the difference in mean symptom ratings, between the patient, 21.28 
mm and the family, 22.96 mm (scored out of 100 mm), was not 
statistically significant. When converted to the same scale the Lobchuk 
subjeds rated their dyspnoea as being twice as severe as the subjects 
in the present study. Lobchuck calculated the Kappa statistic from a 
binomial scale between ' low' (1/S or 2/S) and 'high' (3/S, 4/S, or SIS) 
symptom ratings, which was equivalent to the 40 out of 100 cut point 
used in the present study. The subjeds in the Lobchuk study were out-
patients with lung cancer who appeared to be sicker than the in-patient 
subjeds from the present study and, unlike the present study subjeds, 
they had family members who agreed with their perceptions of 
shortness of breath. The findings of the present study are at variance 
with the Lobchuk study meaning, perhaps, that at lower levels of 
dyspnoea family members agree less often with the patient than they 
do when this symptom is more distressing. There is mixed evidence 
that patients and family members agree on the ratings of this symptom. 
5.7.2 PATIENT AND NURSE 
No previous studies compared the perceptions of dyspnoea between 
patient and nurse. No agreement was found between nurses and 
patients in the present study (k - 0.11, p - 0.26); while the difference 
between the mean symptom scores of the patient 121.28 mm) and the 
nurse (12.56 mm) was found to be statistically significant (p < 0.002). 
The present findings: that the nurses did not agree w ith, and under-
estimated, their patients' shortness of breath may not be applicable to 
all clinical situations because of diverse nature of the sample and the 
lack of studies in the literature to confirm these findings. 
5.8 NAUSEA 
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5.8.1 PATIENT AND FAMILY 
Lobchuk measured two aspects of nausea and calculated the Kappas 
between patient and family member as 0.47 (p < 0.05) for nausea 
frequency and 0.26 (p - 0.08) for nausea intensity. The raw symptom 
scores, using a 1 to 5 Likert scale, were 1. 78 for the patients on both 
aspects, and 1.81 (frequency) and 2.06 (intensity) for the family 
members. Curtis (23 subjects) found a difference between the mean 
nausea score (out of 1 00 mm) of the patient ( 1 5.3 mm) and of the 
family members (24.4 mm) that was not statistically significant. In the 
present study there was moderate agreement (k - 0.56, p < 0.00), 
while the mean symptom scores showed a difference between patient 
(1 7.66 mm) and family (19.88 mm) that was not statistically significant. 
Again, when converted to the same scale, the patient subjects in the 
Lobchuk study rated their nausea as being almost twice as severe as 
the present study subjects, while the Curtis subjects' ratings were about 
the same as those of the present study's subjects. On the available 
evidence, a conclusion that family members and patients agree on 
symptom ratings of nausea appears justified. 
5.8.2 PATIENT AND NURSE 
Holmes (53 subjects) found a significant difference between the 
perceptions of nausea by patients and nurses reporting that 9 nurses 
under-estimated, 9 agreed with, and 35 over-estimated the patients' 
nausea ratings. Unfortunately the raw scores were not reported. The 
kappa found in the present study was 0.42 (p < 0.00) while the 
difference between the mean nausea scores of the patient (17.66 mm) 
and the nurse (21.74 mm) were not significantly significant. The 
sample in the Curtis study was poorly described as "53 cancer 
patients" so the results there might not be as generally applicable as 
those from the present work. There appears to be mixed evidence that 
cancer patients and nurses agree on the ratings of nausea. 
5.9 DEPRESSION 
5.9.1 PATIENT AND FAMILY 
Clipp (30 subjects) reported the inter-spouse correlation for depression 
as 0.53 with; 43% agreement, 46% over--estimation, and 11% under-
estimation by the spouses. Curtis (23 subjects) found no differences on 
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the ratings of 'fun', 'life satisfaction', and 'quality of life' between the 
patients and family, however this study did not specifically assess 
depression or changes in mood. Unfortunately, neither study reported 
the raw scores. In the present study there was poor agreement between 
patient and family (k - 0.34, p< 0.01), while the inter-spouse 
correlation was strong (rho - 0.47 p < 0.01) for the complete data 
set, and fair (rho - 0.35, p <(0.01) for the binomial data Percent 
agreement was 78"/o. As a trend, there appears to be strong 
concordance, but poor agreement, between patient and family on the 
presence of cancer-related depression. 
5.9.2 PATIENT AND NURSE 
Holmes found a statistically significant difference in mood ratings 
between patients and their nurses (p > 0.001 ), with 7 nurses under-
estimating, 3 agreeing and 43 over-estimating. The raw scores were not 
reported. The present study's statistically significantly di fferent {p -
0.001) depression scores of the patient {18.17 mm) and the nurse 
(28.44 mm) and Kappa of 0.05 {p - 0.59) indicates low levels of 
agreement between the patients and their nurses on the presence of 
depression, with strong evidence that the nurses over-estimated this 
symptom. 
5.10 ANXIETY 
5.10.1 PATIENT AND FAMILY 
No previous studies evaluated the level of agreement or difference in 
perceptions of anxiety between patient and family members. There 
was, in the present study, moderate agreement {k - 0.44, p < 0.001 ), 
fair correlation {rho - 0.49, p < 0.001) on the whole data set, and 
fair correlation {rho - 0.46, p < 0.001) on the binomial data set. 
Despite these findings the conclusion that patients and families agree 
on the presence of anxiety must be made with caution because of the 
absence of previous evidence. 
5.10.2 PATIENT AND NURSE 
No previous studies evaluated the level of agreement or difference in 
perceptions of anxiety between patient and nurse. In the present study, 
there was poor agreement (k - 0.13, p < 0.16), and no correlation 
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(rho - 0.19, p < 0.06) for the full data set or (rho - 0.14, p < 0.20) 
for the binomial data set. As well the difference between patient (26.32 
mm) and nurse {32.28) anxiety scores were not statistically significant. 
Again, the over-all conclusion that nurses and patients do not agree on 
the ratings for anxiety, must be made with caution because of the lack 
of previous data. 
5.11 TIREDNESS 
5.11.1 PATIENT AND FAMILY 
Lobchuk reported a Kappa of 0.63 (p < 0.05) indicating a strong 
agreement between patients and family members on the ratings of 
tiredness. Scored out of 5 on a Likert scale, the difference in the mean 
fatigue scores of 2.95 (patient) and 3.19 (family) were not statistically 
significant. The equivalent findings from the present study were a 
moderate agreement between patient and family lk- 0.47, p < 0.01) 
and a difference between the mean symptom scores of the patient 
(34.01 mm) and the family members (37.73 mm) which was not 
statistically significant. When converted to an equivalent scale the 
Lobchuk subjects rated tiredness as being twice as severe as did the 
subjects in the present study. The high Kappas from both studies offer 
strong evidence that family members perceive tiredness the same as the 
patients. 
5.11.2 PATIENT AND NURSE 
Holmes (53 subjects) found difference (p non significant) between 
nurses' and patients' perception of tiredness that was not statistically 
significant. Unfortunately the raw scores were not given nor was the 
breakdown of the nurses' over- or under-estimations. The equivalent 
findings from the present study included a Kappa of 0.11 (p - 0.24) 
and a significant difference (p < 0.05) between the patients (34.01 
mm) and the nurses (40.12 mm) indicating the opposite of the Holmes 
study. There is no consistent evidence to indicate that patients and 
their nurses agree on the ratings of tiredness. 
5.12 DROWSINESS 
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5.12.1 PATIENT AND FAMILY 
Lobchuk evaluated perceptions of insomnia, which may parallel the 
drowsiness assessed in the present study, and found moderate 
agreement ik - 0.43, p > 0.05) with raw scores (out of 5) of 2.22 
(patient) and 2.65 (family) which was a statistically significant lp > 
0.051 difference. Curtis looked at sleep, which may parallel the 
drowsiness assessed in the present study, and reported a difference 
between the ratings (scored out of 1001 of the patients (33.1 mm) and 
family members 136.3 mmJ which was not statistically significant. The 
present study found a moderate agreement ik - 0.44, p < 0.011 and 
a difference in symptom scores between patient 126.89 mmJ and family 
(24.67 mml that was not statistically significant. Although the Lobchuk 
subjects rated insomnia higher than the present subjeds rated 
drowsiness, there was equivalent agreement on symptom ratings 
between the two studies. If insomnia and drowsiness are equivalent 
symptoms, the conclusion that family members and patients agree on 
their perceptions of drowsiness may be justified. 
5.12.2 PATIENT AND NURSE 
Holmes (53 subjects) assessed the perceptions of sleep, which may 
parallel the drowsiness assessed in the present study, reporting a 
statistically significant (p > 0.05) difference between nurses and 
patient on this symptom rating. Twelve nurses under-estimated, 7 
agreed with, and 34 over-estimated the patients' perceptions of their 
sleeping. The present study findings of a low Kappa; 0.17 (p - 0.081 
and a non significant difference (p - 0.461 in symptom ratings 
between patient 126.98 mml and nurse 124.67 mm). when compared 
with the Holmes study, suggests that no conclusions may be drawn on 
the subject of agreement between nurses and their patients on the 
perception of drowsiness. 
5.13 APPETITE 
5.13.1 PATIENT AND FAMILY 
Lobchuk found a Kappa of 0.60 (p < 0.001) with a non significant 
difference in appetite ratings (scored out of five) between patients 
(2.14) and family (2.41), while Curtis reported on a non significant 
difference between patient (62.0 mm) and family 159.4 mm) on this 
symptom. The present study found a Kappa of 0.44 (p < 0.01) and a 
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non significant difference (p - 0.32) on ratings by patients (42.18 mm) 
and famil y (45.49 mm). When converted to equivalent scales the 
symptom ratings for appetite are about the same between the three 
studies. The lack of significant difference and the moderate to high 
Kappas promote the conclusion that family members agree with the 
patient on the rating of appetite. 
5.13.2 PATIENT AND NURSE 
Holmes found a significant (p > 0.001) difference between patient and 
nurse on the ratings of appetite with 9 nurses under-estimating, 10 
agreeing with, and 34 over-estimating the patients' ratings. 
Unfortunately the raw scores were not provided. The present study's 
Kappa of 0.11 (p - 0.26) and the non significant (p - 0.18) difference 
between patient (42.18 mm) and nurse (47.21 mm) indicates that no 
conclusions should be drawn about agreement on appetite ratings 
between patients and their nurses. 
5.14 WELL BEING 
5. 14.1 PATIENT AND FAMILY 
Curtis found a difference that was not statistically significant (p < 0.71) 
between patient (59.1 mm) and family (56.1 mm) on the ratings, scored 
out of 100 mm, of 'quality of life' which may parallel the symptom of 
'well being' of the present study. The low Kappa of 0.29 and the 
statistically significant (p - 0.02) difference between patient (37.36 
mm) and family (44.95 mm) in the present study is at variance with the 
Curtis study and indicates that no conclusions should be drawn on the 
abilities of families to rate the patients' sense of well being. 
5.14.2 PATIENT AND NURSE 
There were no studies that assessed the nurses' ratings of their patients' 
sense of well being. In the present study there was poor agreement (k 
- -0.07, p - 0.26) between patient and nurse on the rating of well-
being as well as poor correlation (rho - ..0.20 , p - 0.86) using the 
full data set and (rho - ..0.08, p - 0.40) when using the binomial data 
set. The difference between the mean symptom ratings of the patient 
(37.36) and the nurse (47.45) was statistically significant (p < 0.01), 
however the conclusion that nurses consistently over-estimate well-
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being must be made with caution because of the lack of previous data. 
5.15 SUMMARY 
5.15.1 PATIENT AND FAMILY 
There was agreement, in the present study, between patient and family 
on the ratings of nausea (k - 0.56), tiredness (k - 0.47), drowsiness 
(k - 0.44), appetite (k - 0.44), and anxiety (k - 0.44). Except for 
anxiety, for which there were no previous studies with which to 
compare, the levels of agreement agreement found in the present study 
confirm those findings from previous studies. 
There was poor agreement, in the present study, between patient and 
family on the rating of shortness of breath (k - 0.28) which was is at 
variance with the one previous study that assessed this symptom. 
There was not agreement, in the present study, between patient and 
family on the ratings of pain (k - 0.30), depression (k - 0.34), and 
well being (k - 0,29). There was one study comparing quality of life 
that was at variance with the present findings related to well being, 
while studies comparing ratings of pain offered mixed results. 
5.15.2 PATIENT AND NURSE 
There was agreement, in the present study, between patient and nurse 
on the rating of one symptom: nausea (k - 0.42). This finding is at 
variance with the one previous study that assessed this symptom. 
There was over-estimation, in the present study, by the nurses for the 
symptoms of depression, pain, tiredness, and well being; which 
confirms the findings of over-estimation found in previous studies for 
depression. The present findings for pain confirm the mixed levels of 
agreement, correlation, and lack of difference reported from previous 
studies. There were no previous studies that assessed ratings of 
tiredness or well being. 
There was under-estimation, in the present study, by the nurses for 
shortness of breath. There were no previous studies that rated this 
symptom. 
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There was neither agreement nor statistically significant difference, in 
the present study, between patient and nurse on the ratings of anxiety 
(k - 0.13), drowsiness (k - 0.17), and appetite (k - 0.11 ). A previous 
study found over-estimation by the nurses on ratings of drowsiness and 
appetite, while there were no previous studies which assessed the 
ratings of anxiety. 
5.16 CLINICAL ISSUES 
It appears from the analysis of the study results that the family 
members recognize the patient's distress more closely than do the 
nurses. Although it is more likely that the nurses are more knowlegable 
of the meaning and clinical importance of the patient's symptoms than 
are the family, the family members have a much closer relationship 
with the patient and therefore are closer in their ratings of the patient's 
symptoms. 
As most of the study data was collected in the afternoon the nurses 
who completed the ESAS would have had the chance to assess the 
patient in their usual way. However the family members would have 
had the chance to sit w ith the patient and chat for up to many hours 
before completing the ESAS. Time spent with the patient, immediately 
prior to completing the ESAS, might be another factor in the difference 
between family and nurse perceptions of the patient's symptoms. 
Doctors who may rarely meet the family members, and who rely on 
the nursing staff for observations of their hospitalized patients' distress 
might reflect on the nature of this information. Certainly taking the 
time to sit and listen to the patient directly would be the best way of 
all. Nonetheless, doctors working in hospitals have more contact with, 
and may listen more often to their nurse colleagues than to the 
patients' family members. 
5.17 LIMITATIONS 
5.17.1 SAMPLE 
The sample, although drawn from consecutive patients admitted to 
three hospital wards where cancer is treated, may have been biased 
against those patients and families who displayed high levels of 
distress. One possible reason for this distress might be pre-existing 
family pathology exacerbated by the cancer illness; exclusion of such 
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family-subjects might produce a study sample with more contented 
patients surrounded by more closely knit families who might therefore 
be closer in symptom ratings. This sample may only be representative 
of those hospitalized patients with low levels of symptoms making the 
results not applicable to those hospitalized cancer patients who are 
quite ill. 
5.17.2 TYPE OF MALIGNANCY 
The sample, with its high proportion of patients suffering 
haematological malignancies, may not be representative of all 
hospitalized cancer patients. However, as the aim of the study was to 
assess agreement between the study subjects the nature of the 
malignancies suffered by the patient-suhjects may be less important 
than the nature of the relationship between patient and family member 
or between patient and nurse. 
5.17.3 LOCATION OF STUDY 
The study subjects were hospitalized so the results may not be 
generally applicable to the out-patient population with cancer. 
5.17.4 STATISTICS 
Unfortunately the SPSS could not calculate the Kappa on the 100 mm 
scale so the data catagories were collapsed to a binomial scale (using 
the 40 mm cut-off, as have other authors) which lowers the strength of 
the statistical calculation. The calculation of a weighted Kappa was 
beyond the expertise of the author. 
5.18 INSTRUMENT 
In reviewing the raw data the investigator noted that one patient, one 
family member and one nurse (not of the same study triad) rated all 
symptoms as exactly the same, indicating that either all nine symptoms 
were perceived as being of equal intensity, or the subjects didn't 
understand the process, or were too busy or distracted to be bothered 
with careful completion of the ESAS. 
While instructing and observing the study subjects in the completion 
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of the ESAS the investigator noted all subjects completed the forms 
within two minutes. Subjects understood the meaning and method of 
completing the ESAS within five minutes. Those who could not read 
were helped by investigator who read out the descriptive anchors; no 
subjects objected to this and were able to complete the ESAS within 
two minutes. Those subjects who were too weak to write were invited 
to make an imaginary mark along the line with their finger where the 
investigator then made the mark with a pencil; no subjects objected to 
this. 
The nurses were instructed, in groups of three or four; for ten to fifteen 
minutes, in the use of the ESAS before the study began and again 
briefly before the actual data collection. To preserve nurse 
confidentiality no records were kept as to which nurse completed 
which ESAS form; however the investigator noted that rarely did the 
same nurse become involved as a subject more than twice and most 
nurses completed only one ESAS form. Practice bias, therefore, did not 
appear to exist in this study. 
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CHAPTER VI: 
CONCLUSIONS, RECOMM ENDATIONS, AND AREAS FOR FURTHER 
STUDY 
6.1 CONCLUSiONS 
1) Family members agreed with the patients in their ratings 
of 5 out of 9 cancer-related symptoms. 
2) Nurses agreed with the patient on the rating of 1 out of 
9 cancer-related symptoms. 
3) Family members over-estimated the patients' ratings of 
well being. 
4) Nurses over-estimated the patients' ratings of well being, 
tiredness, depression, and pain. 
5) Nurses under-estimated the patients' ratings of shortness 
of breath. 
6) Family members were closer, than were the nurses, in 
their perceptions of the patients' cancer-related 
symptoms. 
6.2 RECOMMENDATIONS 
1) Nurse who treat hospitalized patients suffering from a 
malignancy should obtain information regarding cancer-
related symptoms by listening first to the patient. If the 
patient is not able to communicate with the nurse, the 
family should be the next source of this information. 
2) Because of ambiguity in the meaning, low levels of 
agreement between the dyads, and lack of evidence from 
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previous studies, the VAS sub-scale for well being should 
be deleted from the ESAS. 
3) Because of ambiguity in meaning, confusion with the 
symptom of tiredness, and lack of evaluation of this 
symptom in previous studies the symptom of drowsiness 
should be replaced, in the ESAS, by a VAS for sleep. The 
anchoring statements might read: "Worst possible sleep 
last night" and "'Best possible sleep last night". 
6.3 AREAS FOR FURTHER STUDY 
This study evaluated a one time use of the ESAS in patients who were 
not so ill as to refuse the study because of physical or emotional 
distress. Would once or twice daily assessments show the same levels 
and distribution of agreement? As the patients became sicker with 
progression of disease would agreement be the same when the 
symptom ratings were higher? 
Patient outcome and the question of whether using the ESAS to assess 
patient symptoms is of value in increasing patient comfort? was not 
addressed in this study. One area of further study could be to regularly 
record the patients' symptom perceptions using the ESAS and record 
what comfort measures were instituted based on these scores. 
The main findings of the present study: the family members are closer 
in their perceptions of the patients' distress than are the nurses could 
be further assessed by a longitudinal study using, perhaps dai ly, 
repeated measures by family members patients and nurses. 
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Name: -------------------------------
Room 1: ----------- Tl.,.: ------------
Plout CIOII lilt Ont tllllt polrllllltl bttl d•tcrlht: (For~ing) 
Wont poulbl' 
No pain ---------------- pain 
Not tired 
Wont posalbl 
----------------- llrednen 
Wortt poulbt 
Not nauseated -------------------------------- nau1e1 
Wontpoulbl 
Not depreued ------------------------------ depresalon 
Wontponlb 
Not anxloua ------------------------------- anxiety 
Wontpoulb 
Not droway ---------------------------- drowtlneu 
Bealpoulblt 
appetite -------------------------------- No tppellla 
Besl ponlblt Wont ponli 
"nsallon ol aentallon o 
wellbeing wellbeing 
No thortneaa Wortt pou 
ol breath ------------------------- ahortneu c 
~b~----------------------
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FACULTY OF MEDICINE 
MEMORIAL UNIVERSITY OF NEWFOUNDLAND 
ST. JOHN'S, NEWFOUNDLAND AlB JV6 
CONSENT TO PARTICIPATE IN BIO-MEDICAL RESEARCH 
TITLE: Symptom assessment of hospital patients: a comparison of rating scores 
supplied by the patient, the family, and the nurse. 
INVESTIGATOR: Dr. Bill Eaton 
Oepanment ofF amily Practice 
Health Science Centre 
737 6744 
You, your nurse and one of your family, have been asked to participate in a research 
study. Your panicipation in this study is entirely voluntary. You may decide not to 
participate or you may withdraw from the study at any time without affecting your usual 
treatment. 
Confidentiality of information concerning you will be maintained by Dr. Eaton. 
Or. Eaton will be available during the study should you have any problems or questions 
about the study. 
This study will compare your evaluation of your symptoms (how you are feeling) with the 
evaluation done by one of your family and by your nurse. Other researchers have found 
that nurses, patients, and family tend to evaluate the patient's symptoms differently. By 
finding the special ways that patient, family, and nurses evaluate the patient's symptoms 
the investigator hopes to develop strategies to assist patient and family cope with serious 
illness. 
Patient I 
I. Purpose or study: To compare your estimation of your symptoms with the estimations 
of your symptoms done by your nurse and by a close family member. 
2. Description of procedures and tests: You, your next of kin or close family 
member, and your nurse will be asked to complete a simple fonn that rates nine symptoms 
commonly suffered by people with serious illness such as cancer. 
3. Duration of subject's participation: Less than one half hour to discuss the study, 
sign a consent form and complete the symptom assessment form. 
4. Foneeable risks, discomforts, or inconveniences: 
rating fonn take between 20 and 90 seconds. 
Completion ofthe symptom 
S. Benents the subject may receive: 
participation. 
There are no guaranteed benefits from 
6. Alternative procedures or treatment for those not entering the study: 
care will not be affected whether or not you choose to enter the study. 
Patient 
7. Uability statement. "Your signature on this fonn indicates that you have 
undentood to your satisfaction the information regarding your participation in the 
research project and agree to participate as a subject. In no way does this waive 
your legal rights nor release the investig::uor, sponsors, or involved institutions from 
their legal and professional responsibilities." 
Patient2 
I, the undersigned, agree to my panicipation in the study 
of symptom assessment and to the panicipation of my next of kin or close family member 
· (name of family member), and to the panicipation of my 
nurse. 
Any questions have been answered and I understand what is involved in the study. 
realize that panicipation is voluntary and that there is no guarentee that I will benefit from 
my involvement. I acknowlege that a copy of this form has been given to me. 
(Signature ofPanicipant) (Date) 
(Witness Signature) (Date) 
To be signed by investigator 
To the best of my ability I have fully explained to the subject the nature of this research 
study. I have invited questions and provided answers. I believe that the subject fully 
understands the implications and voluntary nature of the study. 
(Signature oflnvestigator) 
Telephone number: 737 6477 
To Be Signed By A Physician 
(Date) 
(not a co.investigator or otherwise involved in this trial) 
"I believe that this subject fully undentands the implications 
and voluntary nature or the study and is competent to enroll 
iD this research study." 
(signature of second physician) 
Patient 3 
(Date) 
APPENDIX Ill 
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FACULTY OF MEDICINE 
MEMORIAL UNIVERSITY OF NEWFOUNDLAND 
ST. JOHN'S, NEWFOUNDLAND AlB JY6 
CONSENT TO PARTICIPATE lN BIO-MEDICAL RESEARCH 
TITLE: Symptom assessment in hospital patients: a comparison of rating scores 
supplied by the patient, the family, and the nurse. 
!NYEST!GATOR: Dr. Bill Eaton 
Department ofF amily Practice 
Health Science Centre 
737 6744 
You and your family member, presently a patient in this hospital, have been asked to 
participate in a research study. Your participation in this study is entirely voluntary. You 
may decide not to participate or you may withdraw from the study at any time without 
affecting the usual treatment. 
Confidentiality of information concerning you will be maintained by Dr. Eaton. 
Dr. Eaton will be available during the study should you have any problems or questions 
about the study. 
If you agree you will be asked to evaluate the symptoms suffered by your family member 
by filling out a short form. The nurse caring for your family member will also complete a 
similar form. The investigator will compare your evaluation with those done by your 
family member and by the nurse. Other researchers have found that nurses, patients, and 
family tend to evaluate the patient's symptoms differently. By finding the special ways that 
patien~ family, and nurses evaluate the patient's symptoms the investigator hopes to 
develop strategies to assist patient and family cope with serious illness. 
Family I 
I. Purpose of study: To compare your estimation of the patient's symptoms with the 
estimations of these symptoms done by the patient and by the nurse .. 
2. Description of procedures and tests: You, your family member presently a patient 
in this hospital, and the nurse will be asked to complete a simple form that rates nine 
symptoms commonly suffered by people with serious illness such as cancer. 
3. Duratioa of subject's participation: Less than one half hour to discuss the study, 
sign a consent form and complete the symptom rating form. 
4. Foneeable risks, discomforts, or inconveniences: 
rating form take between 20 and 90 seconds. 
Completion of the symptom 
S. Benerits the subject may receive: 
participation. 
There are no guaranteed benefits from 
6. Alternative procedures or treatment for those not entering the study: 
care will not be affected whether or not you choose to enter the study. 
Patient 
7. Liabilil)' statemenL "Your signature on this form indicates that you have 
understood to your satisfaction the information regarding your participation in the 
research project and agree to participate as a subjecL In no way does this waive 
your legal rights nor release the investigator, sponsors, or involved institutions from 
tbeir logaland professional responsibilities." 
Family 2 
I, the undersigned, agree to my participation in the study 
of symptom assessment as described. 
Any questions have been answered and I understand what is involved in the study. I 
realize that participation is voluntary and that there is no guarentee that I will benefit from 
my involvement. I acknowlege that a copy of this form has been given to me. 
(Signature of Participant) (Date) 
(Witness Signature) (Date) 
To be signed by investigator 
To the best of my ability I have fully explained to the subject the nature of this research 
study. I have invited questions and provided answers. I believe that the subject fully 
understands the implications and voluntary nature of the study. 
(Signature of Investigator) 
Telephone number: 737 6477 
family 3 
(Date) 
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FACULTY OF MEDICINE 
MEMORIAL UNIVERSITY OF NEWFOUNDLAND 
ST. JOHN'S, NEWFOUNDLAND AlB JV6 
CONSENT TO PARTICIPATE IN BIO-MEDICAL RESEARCH 
TITLE: Symptom assessment in cancer patients: a comparison of rating scores 
supplied by the patient, the family, and the nurse. 
!NVESTIGA TOR: Dr. Bill Eaton 
Department of Family Practice 
Health Science Centre 
737 6744 
You, a nurse in this hospital, have been asked to participate in a research study. Your 
participation in this study is entirely voluntary. You may decide not to participate or you 
may withdraw from the study at any time without affecting the usual treatment. 
Confidentiality of information concerning you will be maintained by Dr. Eaton. 
Dr. Eaton will be available during the study should you have any problems or questions 
about the study. 
If you agree you will be asked to evaluate, by filling out a short form. the symptoms 
suffered by some of your cancer patients if they agree to take part in this study. The 
investigator will compare your evaluation with those done by the patient and by a family 
member. Other researchers have found that nurses, patients, and family tend to evaluate 
the patient's symptoms differently. By finding the special ways that patient, family, and 
nurses evaluate the patient's symptoms the investigator hopes to develop strategies to 
assist patient and family cope with serious illness. 
Nurse I 
l. Purpose of study: To compare your estimation of the patient's symptoms with the 
estimations of these symptoms done by the patient and by a f~mily member. 
2. Description of procedures and tests: You, your patient and a close family member 
will be asked to complete a simple form that rates nine symptoms commonly suffered by 
people with serious illness such as cancer. 
3. Duration of subject's participation: Less than one half hour to discuss the study, 
sign a consent form and complete the symptom rating form . 
4. Forseeable risks, discomforts, or inconveniences: 
rating form take between 20 and 90 seconds. 
Completion of the symptom 
S. Benefits the subject may receive: 
participation. 
There are no guaranteed benefits from 
6. Altentative procedures or treatment for those not entering the study: 
care will not be affected whether or not you choose to enter the study. 
Patient 
7. Liability statement. "Your signature on this form indicates that you have 
•adentood to your satisfaction the infonnation reg.arding your participation in the 
research project and agree to participate as a subject. ln no way does this waive 
your legal rights nor release the investigator, sponsors, or involved institutions from 
their legal and professional responsibilities." 
Nurse 2 
L the undersigned, agree to my participation in the study 
of symptom assessment as described. 
Any questions have been answered and I understand what is involved in the study. I 
realize that participation is voluntary and that there is no guarentce that I will benefit from 
my involvement. lack.nowlegethat a copy of this form has been given to me. 
(Signature of Participant) (Date) 
(Witness Signature) (Date) 
To be signed by investigator 
To the best of my ability I have fully explained to the subject the nature of this research 
study. I have invited questions and provided answers. I believe that the subject fully 
understands the implications and voluntary nature of the study. 
(Signature•oflnvestigator) 
Telephone number: 737 6477 
nurse 3 
(Date) 
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CANADIAN MENTAL STATUS EXAMINATION FORM 
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1l!E CANADIAN MEI(l"AL STATUS QUESTIONAIRE 
(MSQJ 
This test \\as developed by Robertson and Rockvoood i.n Sask.atc~an in the early 1980's and 
has been validated to assess cognitive imp3innent. Scores below 2110 indicue 5e\'Cr cognitive impainnent 
while scares between 2110 and 7110 indicate moderate irnpainnent Those who score above 7110 are either 
DOt impaired or mildly impaired. This test is used bc::c:ause it is very quick and non-intrusi\·e. The test is 
giveo orally. 
MSQ 
I) Full name 
2) Addms 
3) Age 
4) Present day 
$) Present month 
6) Present year 
7) Year WW I began 
I) Name of Canada's Prime Minister 
Ask subjcd to listen to and repeat and recaJJ thtcc items: 
Bed. Chair. Window 
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